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Nota Prévia 
 
A presente tese encontra-se escrita em inglês e em formato de publicação. A língua inglesa foi 
escolhida para ser usada por ser hoje em dia a língua franca da comunidade científica, e ao 
pretender seguir uma carreira de investigação impõe-se a necessidade de um domínio 
crescente dessa língua. 
Adicionalmente, o inglês é também utilizado devido ao formato de publicação científica desta 
tese. O projeto desenvolvido ao longo do último ano resultou num artigo científico submetido 
à revista Cell. Como tal, a presente tese inclui não só resultados das análises computacionais 
realizadas, mas também validações biológicas experimentais complementares ao trabalho 
desenvolvido, que permitem uma melhor compreensão da questão biológica abordada. No 
entanto, este relatório pretende salientar o trabalho desenvolvido pelo autor no referido 
projeto, isto é, a análise de dados de sequenciação de alto rendimento usando software 
adequado a cada teste, como será descrito mais à frente. Os capítulos desta tese, incluindo não 
só o Capítulo 2, que contém o artigo, mas também os restantes, estão assim escritos em 
formato idêntico ao utilizado na submissão de manuscritos à referida publicação, mas com a 
inclusão de figuras ao longo do texto, a fim de facilitar a leitura e compreensão. Para facilitar 
a compreensão, foi também dado um estilo diferente aos títulos e subtítulos. 
  
III 
 
Resumo 
 
A transcrição é o processo, presente em todos os seres vivos, em que a partir de uma cadeia 
molde de DNA se sintetiza uma cadeia complementar de RNA. A grande maioria dos genes 
em eucariotas é transcrita pela RNA polimerase II. A cadeia de RNA sintetizada não é, no 
entanto, o produto final, já que pode ser alvo de vários tipos de processamento, como splicing, 
poliadenilação ou edição de bases. Estes fenómenos foram já descritos como ocorrendo co ou 
pós-transcricionalmente. No entanto, não são ainda conhecidos todos os componentes, nem 
como são regulados estes processos ou qual a sua interação com a RNA polimerase II, em 
particular com o seu domínio carboxi-terminal (CTD). 
Para abordar estes problemas de uma forma não enviesada, optou-se por adaptar uma técnica 
anteriormente descrita, que abrange todo o genoma, de alto rendimento e precisão, a native 
elongating transcript sequencing (NET-seq); sendo ela modificada de modo a poder detetar 
qual o estado de fosforilação do domínio carboxi-terminal da polimerase isolada em cada 
ensaio. Ao novo protocolo chamou-se advanced NET-seq (ANET-seq). Para além dos dados 
gerados por este protocolo, foram também obtidos dados de RNA ligado à fração de 
cromatina (ChrRNA). Todos os dados foram obtidos de células HeLa, sendo esta a primeira 
instância em que um estudo de nível genómico com esta precisão de mapeamento foi aplicado 
em mamíferos. 
Análise inicial destes dados revelou uma distribuição das isoformas do CTD nos genes 
idêntica ao previamente descrito por outras técnicas. Adicionalmente, verificou-se também a 
captura de precursores do splicing, nomeadamente do 3’ do exão upstream, distintamente nos 
casos em que este é incluído no transcrito final. Estes exões aparecem principalmente 
associados a polimerase fosforilada na serina 5 do seu CTD. Outra observação curiosa foi a 
deteção de precursores do processamento de micro RNAs pelo complexo Drosha/DGCR8. 
Diferenças na deteção destes precursores permitiu postular diferentes dinâmicas para o 
processamento destes RNAs não codificantes. 
Também se obtiveram dados de ANET-seq (com anticorpo para fosforilação da serina 2) e 
ChrRNA de células HeLa transfetadas com siRNA contra fatores de terminação – Xrn2 - e 
processamento do terminal 3’ do pre-mRNA – CPSF73 e CstF64+CstF64τ. Análise destes 
dados permitiu concluir que os fatores de processamento, mas não o Xrn2, influenciam 
significativamente a dinâmica da polimerase na região 3’ do gene, no final da transcrição, 
promovendo a sua pausa e subsequente desassociação do DNA. Constatou-se também que 
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estes fatores afetam a acumulação de polimerase junto ao promotor dos genes, afetando 
igualmente a produção de transcritos upstream do promotor (PROMPTs), podendo concluir-
se que estes fatores participam na regulação da transcrição não-produtiva. 
Os resultados obtidos foram satisfatórios e também surpreendentes. Com este trabalho, é 
apresentada uma nova forma de estudar, ao nível do genoma, como ocorre a regulação da 
transcrição pelo CTD. Mostram-se também novas provas sobre processamento co-
transcricional do RNA e a sua ligação à fosforilação do CTD. Foram igualmente elucidados 
os papéis de alguns fatores envolvidos na fase final da transcrição. Finalmente, ficou outra 
vez demonstrada a importância de estudos abrangentes na área da transcrição, em 
complemento dos trabalhos moleculares e bioquímicos já desenvolvidos há décadas. Espera-
se, de futuro, um aprofundamento das técnicas de alto rendimento, e uma consequente 
adequação das ferramentas bioinformáticas a estes estudos. 
 
Palavras-chave: transcrição; ANET-seq; sequenciação de RNA; CTD; splicing; micro RNA; 
clivagem e poliadenilação; terminação. 
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Abstract 
 
Transcription is a process present in all living beings where, from a DNA template, a 
complementary RNA strand is synthesized. Most eukaryotic genes are transcribed by RNA 
polymerase II. The resulting RNA strand is not, however, the final product, since it’ll still be 
subject to various processing steps, such as splicing, polyadenylation or base editing. These 
modifications have been described as occurring co or post-transcriptionally. Yet, it is still not 
known how these processes are regulated, nor what all of their interveners are or how do they 
interact with RNA polymerase II, in particular with its C-terminal domain (CTD). 
To address these problems in an unbiased way, a previously described genome-wide and 
high-precision technique, native elongating transcript sequencing (NET-seq), was adapted so 
it could detect what was the phosphorylation isoform from the isolated polymerase’s CTD. 
The new protocol was called advanced NET-seq (ANET-seq). In addition to the data 
generated by this protocol, RNA associated with the chromatin fraction was also sequenced. 
All data was obtained from HeLa cells, applying this genome-wide high-resolution technique 
to a mammalian system. 
Initial analysis of ANET-seq data revealed that distribution of CTD isoforms in genes was 
similar to previously described profiles obtained by other protocols. Additionally, it was also 
verified the capture of splicing intermediates, in particular the 3’ end of the upstream exon, 
distinctively in cases where it was included in the final transcript. These exons are mainly 
associated with polymerase phosphorylated in the CTD’s Ser5. Another curious observation 
was the detection of micro RNA precursors, resulting from Drosha/DGCR8 processing. 
Differences in the detection of these precursors allowed the proposal of different processing 
dynamics for this type of non-coding RNAs. 
ANET-seq data (with a Ser2-directed antibody) and ChrRNA from HeLa cells transfected 
with siRNA for termination factor Xrn2 and 3’ processing factors CPSF73 and 
CstF64+CstF64τ were also obtained. The analysis of this data showed that 3’ processing 
factors, but not Xrn2, significantly influence Pol II dynamics in the gene’s 3’ region, at the 
end of transcription, promoting its pause and dissociation from the DNA template. It was also 
observed that these factors influence polymerase accumulation near gene’s promoters, and 
equally affect promoter upstream transcripts (PROMPTs), leading to the conclusion that these 
factors regulate termination of unproductive transcription. 
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Obtained results were satisfactory and also sometimes surprising. This work presents a novel 
genome-wide way to study how transcription is regulated by the CTD. New evidence of co-
transcriptional RNA processing arouse, as well as their connection with CTD isoforms. There 
were also new revelations about transcription termination factor’s functions. Finally, it was 
once again demonstrated the importance of genome-wide techniques in transcription study, 
which complete molecular and biochemical work in the same area that has been developed for 
decades. In the future, a greater development of high-throughput techniques, and a constant 
adaptation of bioinformatical tools to these studies is expected. 
 
Keywords: transcription; ANET-seq; RNA sequencing; CTD; splicing; micro RNA; cleavage 
and polyadenylation; termination. 
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1. Transcription 
1.1 Overview 
 
In 1956, Francis Crick first proposed what he called the “Central Dogma of Molecular 
Biology”. The Dogma not only stated, in his own words, that “Once information has got into 
a protein it cannot get out again”, but 
also outlined the possible ways this 
information would be transferred 
between nucleic acids and proteins. 
Later, in 1970, Crick developed these 
ideas, and classified the nine possible 
ways information could be 
transferred between the intermediates 
(DNA, RNA and protein) into three 
categories: General Transfers, 
Special Transfers and Unknown 
Transfers (Francis Crick, 1970) 
(Figure 1). General Transfers refer 
to reactions present in all cells, 
whereas Special Transfer refers to reactions that were postulated to exist, and later identified 
only in a subset of life forms or in vitro (Uzawa et al., 2002). Unknown Transfers are 
reactions postulated not to exist since they would require very complex machinery. Although 
great advancements and discoveries have been made in the field of molecular biology, the 
core message of the dogma still holds, yet it does not address certain details of the described 
phenomena, such as gene expression regulation or post-translational modifications. 
According to the Dogma, information is stored in the DNA nucleotide sequence, and to be 
effectively used to produce proteins uses an intermediary, RNA. Transcription is the synthesis 
of RNA using DNA as a template. Although the interveners vary greatly between prokaryotes 
and eukaryotes, the core process is very similar. The main player in transcription is RNA 
polymerase, which reads the DNA strand and synthesizes a complementary RNA molecule 
(Chamberlin and Berg, 1962). Like any complex biochemical reaction, eukaryotic 
transcription can be divided in several steps. These steps are defined by the different factors 
that associate with the polymerase and the transcribed gene’s sequence in a given moment. 
Figure 1: A representation of the Central Dogma of Molecular Biology, 
including DNA (top), RNA (bottom left) and protein (bottom right), and 
the possible information transfers between them (arrows). Green, 
General Transfers; Yellow, Special Transfers; Red, Unknown Transfers. 
1 – DNA replication; 2 – Transcription; 3 - Translation 
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The progression of transcription in each phase, however, depends not only on these factors, 
but also on chromatin conformation and components, and also the gene sequence (Nojima et 
al., 2013; Grosso et al., 2012; Peterlin et al., 2006; Jonkers et al., 2014). In addition, 
eukaryotes possess different RNA polymerases, each responsible for the transcription of a 
subset of genes. This results in a highly regulated process, allowing the cell to precisely adjust 
its components’ concentration in response to diverse stimuli. 
 
1.2 The RNA Polymerase II and the C-Terminal Domain 
 
As previously mentioned, RNA polymerase is the main agent involved in transcription, 
synthesizing RNA in a DNA-dependent manner. It is an essential enzyme for all organisms - 
even virus, which may use the host’s 
polymerase -, but despite that there are 
many differences, mainly structural but 
some also functional, between 
prokaryotes and eukaryotes. 
In animals, three RNA polymerases 
exist (Roeder and Rutter, 1969). RNA 
polymerase I (Pol I) is responsible for 
transcription of pre-45S rRNA, which 
generates all the other mature rRNA 
except 5S (Jacob, 1995), whereas RNA 
polymerase III (Pol III) is involved in the 
production of tRNAs, rRNA 5S, a small 
subset of micro RNAs and other small 
RNAs found in the nucleus and cytosol 
(Weinman and Roeder, 1974; Willis, 
1993). As for all the other transcripts, 
Figure 2: Top - Back view of the RNA polymerase II 
complex structure, and a scheme of the CTD sequence. 
RPB1 in grey, RPB2 in bronze, RPB4 in red, RPB6 in 
green, RNP domain of RPB7 in blue, C-terminal of 
RPB7 in light blue and the rest in black. Structure from 
Bushnell and Kornberg, 2003. Bottom – CTD post-
translational modifications. Filled circles indicate 
existence, open circles indicate inexistence. Yellow, 
phosphorylation; Blue, glycosylation; Green, proline 
cis-trans isomerization. 
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including all mRNAs, their production is attributed to RNA polymerase II (Pol II). 
Human Pol II is a 550kDa protein complex, composed of 12 different subunits (Acker et 
al., 1997). The whole complex is highly conserved among eukaryotes, and most of its 
subunits are interchangeable among species without any prejudice for transcription 
(Shpakovski et al., 1995). Therefore, many structural and functional studies are conducted 
using yeast Pol II, considered the archetype for eukaryotic RNA polymerases. Some subunits 
have a function of their own, whereas others interact to give rise to a function, as is the case 
for the subunits that constitute the active site (Acker et al., 1997; Woychik and Hampsey, 
2002). In addition to the enzyme itself, there are also other components that constitute the 
RNA polymerase II holoenzyme (Myer and Young, 1998). The holoenzyme is the complex 
recruited to eukaryotic promoters, including the core enzyme and the proteins that recognize 
promoters or enhancers, and also factors whose function is to remodel the chromatin, 
allowing transcription to proceed. 
From the 12 subunits that make Pol II, RPB1 is the largest, and, in interaction with others, 
constitutes part of the enzyme’s active site (Cramer et al., 2001). But RPB1 has other 
important regions, like its C-Terminal Domain (CTD) (Figure 2).  This is a structurally 
disordered region, composed of a repetition of the heptapeptide Tyrosine-Serine-Proline-
Threonine-Serine-Proline-Serine (Y-S-P-T-S-P-S). Although the heptapeptide itself is highly 
conserved among eukaryotes, the number of tandem repetitions varies greatly, from 26 in 
Saccaromyces cerevisiae, to 42 in Drosophila melanogaster, 34 in Arabidopsis thaliana and 
52 in vertebrates. The CTD amino acids serve as targets for reversible post-translational 
modification of Pol II. These changes are intrinsically linked to the dynamics of transcription 
and its associated phenomena, yet some modifications assume more preponderant roles than 
others in the progression of transcription. The most common modifications are the 
phosphorylation of Ser2 or Ser5 (Phatnani and Greenleaf, 2006), but other residues can be 
modified in various ways (Figure 2, bottom). 
 The main, general role of the CTD, along with its modifications, is to act as a scaffold, 
recruiting different interveners of transcription and RNA modifiers. The post-translational 
modifications are the cause behind the multitude of CTD interactions, allowing for a fine tune 
of RNA synthesis and modification. All amino acids of the heptad have modifications 
associated to them, and although some of these are mutually exclusive (phosphorylation and 
glycosylation, for example), the number of possibilities allows for a wide range of 
combinations. In addition, other non-consensus residues may also be modified, as is the case 
for arginine 1810 methylation (Sims et al., 2011), which regulates CARM1 activity, involved 
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in some snRNA and snoRNAs expression. Non-consensus lysines were also demonstrated to 
be the target of an ubiquitin-protein ligase in mice (Li et al., 2007). 
From the most studied marks – serine phosphorylations – the first to appear in a gene’s 
transcription is Ser5, highly associated with the promoter, although it can still be found in the 
rest of the gene. This mark has been particularly linked to 5’ capping, H3K4 trimethylation 
and early termination events (Terzi et al., 2011; Komarnitsky et al., 2000). Ser7 
phosphorylation is also an early mark in transcription, but it generally extends further than 
Ser5, despite their ChIP pattern being very similar (Kim et al., 2009). Ser7 is associated with 
the Integrator machinery, responsible for snRNA processing (Egloff et al., 2007). However, 
Ser7 is a less conserved position in the CTD heptad, sometimes replaced by arginine or 
lysine. Usually after promoter clearance, Ser2 phosphorylation begins to be observable. This 
does not mean that other marks disappear, since it is well described the double marking 
Ser2P-Ser5P along the gene body, and is responsible for recruiting SET2, inducing the 
methylation of H3K36. Phosphorylation of Ser2 is carried out by CDK9, a Ser5P-dependent 
kinase part of the P-TEFb complex, but only when there’s a relation with splicing and 
termination events (Napolitano et al., 2013). CDK9-driven phosphorylation was once also 
thought to be related to transition to productive elongation, but it in fact drives such transition 
by catalyzing the phosphorylation of SPT5, a subunit of the DSIF complex (Garber et al., 
2000). It is now believed that CDK12 is the kinase responsible for elongation-associated 
phosphorylation of the CTD (Bartkowiak et al., 2010). 
Other CTD modifications seem to have more specific roles, and consequently they’re 
function is not well known or studied. Thr4 phosphorylation, for example, is known to be 
involved in histones 3’end processing (Hsin et al., 2011). Glycosylation is also not very well 
described, but it is postulated to regulate phosphorylation, as the two are mutually exclusive. 
The fact that so many transcription-related processes seem to have elements interacting 
with the CTD repeats of the largest Pol II subunit makes them a prime target for studies in 
transcription regulation and dynamics. But, in spite of the knowledge gained from genome-
wide ChIP studies about where in the gene each CTD isoform appears, it is still fairly 
misunderstood when in a gene’s transcription the phosphorylation/dephosphorylation of some 
of these amino acids happens, in particular the widely studied Serine 2 and Serine 5 
phosphorylations. It can be concluded that a technology that can map these CTD patterns with 
elevated precision and in a genome wide fashion is essential to reveal their relationship with 
gene sequence, co-transcriptional processing or regulation events. 
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1.3 Stages and players of transcription 
 
It is possible to define at least eight steps for the whole transcription process in eukaryotes 
(Fuda et al., 2009): chromatin opening, pre-initiation complex formation, initiation, promoter 
clearance, escape from pausing, productive elongation, termination and recycling. These can 
also be summarized in initiation (comprising the aforementioned initiation, promoter 
clearance and escape from pausing), elongation and termination, in order to highlight the 
beginning, development and end of the RNA molecule synthesis. As previously stated, these 
stages are characterized by specific elements, resulting in a fine regulation of transcription. 
Initiation, the first stage of active transcription, depends on the opening of chromatin and 
pre-initiation complex assembly. Chromatin opening consists on unwinding DNA from 
nucleosomes, mainly by histone acetylation, a modification very early described to promote 
RNA synthesis (Allfrey et al., 1964; Hebbes et al., 1988). Conversely, gene silencing is 
usually promoted by histone methylation (Chen et al., 1999), as is the case for H3K9me3 
histone mark (for silenced promoters), but not for H3K4me3 (active promoter, present at the 
transcription start site), H3K36me3 and H3K79me2 (active gene body), which collectively 
indicate the presence of an actively transcribed gene (Kouzarides, 2007). After chromatin 
remodeling, pre-initiation complex assembly – which corresponds to RNA polymerase and 
general transcription factors – occurs, according to the core promoter elements present, and is 
regulated by distal and proximal enhancers (Stargell and Struhl, 1996). 
Although pre-initiation complex assembly makes Pol II essentially ready to start 
transcribing, it won’t always occur. Many times initiation is a rate-limiting step in 
transcription, resulting in an accumulation of RNA polymerase at the transcription start site 
(TSS). Initiation can be regulated in the open complex formation step, promoter clearance by 
dethatching from pre-initiation complex factors, or escape from promoter-proximal pausing 
(Saunders et al., 2006). In particular, promoter-proximal pausing is responsible for most of 
the accumulation of polymerase in the TSS region. This stage is known to be regulated by P-
TEFb, a complex that includes a Ser2 kinase for the C-terminal domain (CTD) of RNA 
polymerase II (Pol II), and that enables its transition to productive elongation (Ni et al., 2008). 
P-TEFb not only phosphorylates Pol II, but also some factors that contribute negatively to 
elongation, such as DRB Sensitivity Inducing Factor (DSIF). Shortly, DSIF interaction with 
the Negative Elongatin Factor (NELF) and Pol II is disrupted by the kinase activity of P-
TEFb, thus allowing for the polymerase to advance, with a hyperphosphorylated CTD 
(Yamaguchi et al., 1999). This promoter-pausing regulation mechanism allows for a fast 
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response to environmental changes in terms of gene expression, as was attested by the 
description of this mechanism in Drosophila melanogaster hsp70 gene (Boehm et al., 2003). 
During elongation, fewer factors seem to be involved in transcription regulation. However, 
polymerase progression is not constant. Productive elongation requires chromatin remodeling 
by removing nucleosomes out of the way (Orphanides et al., 1998; Belotserkovskaya et al., 
2003). More recently, it has been demonstrated that pausing is highly correlated with 
nucleosomes and sequence (Chruchman and Weissman, 2011, Grosso et al., 2012), and also 
that elongation rates are correlated to GC content, DNA methylation and exon density, 
suggesting a connection to splicing (Jonkers et al., 2014). 
Transcription termination is the hardest phase of transcription to study, due to its many 
interveners, its variability between genes and the difficulty to establish an in vitro system that 
replicates it. Nevertheless, it has been described that transcription proceeds after the 
polyadenylation (pA) site, peaking on average about 1.5kb after this sequence (Core et al., 
2008). However, evidence also shows that this is not a general feature, and depends on the 
gene’s transcription rate and magnitude (Grosso et al., 2012). A more detailed and 
mechanistic description will be presented next.  
 
 
2. Pre-mRNA Processing 
2.1 Splicing 
 
When the Human Genome Project started in 1990, no one would still believe that the 
human genome contained the 6.7 million genes proposed in 1964 by Friedrich Vogel. 
However, the estimate at the time would still be about 5 times larger than the most recent 
number of about 19000 (Pertea and Salzberg, 2010; Ezkurdia et al., 2014). More so, being this 
value very close to the predicted number of genes in other invertebrates (and, in general, less 
complex life forms), there was a realization that phenotype diversity wasn’t that much 
dependent of protein-coding genes number. However, protein diversity – which accounts for 
part of phenotype diversity, together with expression regulation - can be achieved by other 
means, such as post-translational modification and alternative splicing. It has been shown that 
alternative splicing patterns divergence has a relevant role in determining differences between 
vertebrate species (Barbosa-Morais et al., 2012). Exon skipping seems to be the most 
prevalent form of alternative splicing in this clade – especially in humans –, and more 
 7 
 
relevant than in invertebrates (Kim et al., 2007), but there can are also be other types, like 
alternative donor or acceptor sites and retained introns (Sammeth et al., 2008). 
But not all introns are subjected to alternative splicing, meaning that generating diversity is 
not the sole reason why introns exist. While their origin is highly debatable, they are 
maintained in large genomes because the organism can support their energetic cost and 
because they are not very disadvantageous, even when suffering insertions or deletions 
(Lynch and Conery, 2003). Introns can then be made useful to genomes, as is the case with 
alternative splicing previously explained. Introns are also associated with many non-coding 
RNAs (ncRNA), which can be excised after splicing occurs (Rearick et al., 2011), and with 
regulatory roles (Jonsson et al., 1992; Hughson and Schedl, 1999). 
Figure 3 shows how the known types of splicing can be organized. Most introns depend on 
the spliceosome for their excision, but some are capable of it by themselves, through more or 
less similar mechanisms. Trans-splicing is a distinct case in spliceosome-dependent splicing, 
occurring only in a restricted number of species, and it involves splicing together two exons 
from different genes (Bonen, 1993). 
Most introns undergo splicing through the major spliceosome pathway. The major 
spliceosome is composed of several ribonucleoproteins (RNPs), consisting in associations of 
one or two small nuclear RNA (snRNA) and proteins. The snRNA that are part of this 
structure are U1, U2, U4, U5 and U6. U4 and U6 are assembled together in the same RNP, 
Figure 3: scheme organizing the known different types of 
splicing. The ones highlighted in green are the most 
common ones, and they follow the depicted biochemical 
reaction (from Black, 2003). In these types of splicing two 
transesterification occur. In the first, a nucleophilic attack 
from a specific adenosine forms the lariat intermediate, 
leaving the 3’OH of the upstream exon exposed. In the 
second, the exposed site attacks the 5’ of the downstream 
exon, resulting in the release of the lariat and joining of the 
two exons. 
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whilst the others are each on a different RNP. The association between RNPs and the intron 
varies during splicing, as well as the conformation of the snRNA and proteins (Will and 
Lührmann, 2011) (Figure 4). This process depends on the conservation of the components of 
the spliceosome, but also sequence components of the intron. A mutation in the branch point 
or any of the other conserved sequences will result in defective splicing (Reed and Maniatis, 
1988; Talerico and Berget, 1990). This is also one of the keys to alternative splicing, as 
certain factors may enhance the detection of weaker splice sites, i.e., sequences that are only 
partially similar to the canonical splice sequences (Guiner et al, 2001). 
The minor spliceosome is responsible for the splicing of only about 1 in every 300 
introns (Steitz et al., 2008). This spliceosome contains the unique snRNA U11, U12, U4atac 
and U6atac, and also shares the U5 snRNA with the major spliceosome (Tarn and Steltz, 
1996). This pathway is also characterized by splicing AT-AC introns, which have different 
conserved sequences. Despite the differences, the mechanism employed is very similar to the 
major spliceosome. There is a functional equivalence between U1 and U11, U2 and U12, U4 
Figure 4: Assembly dynamics of the major spliceosome during intron splicing, highlighting interactions between snRNPs 
and the pre-mRNA sequence. From Will and Lührmann, 2011 
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and U4atac, and U6 and U6atac (Will and Lührmann, 2005). However, the minor spliceosome 
includes some proteins not involved in RNP complexes. 
It has been shown that splicing can occur not only post-transcriptionally, but also co-
transcriptionally (Beyer and Osheim, 1988). Although there is much evidence that this 
phenomenon is widespread, and that the spliceosome actually co-localizes with nascent 
transcripts (Lacadie et al., 2006), it has proven difficult to establish how it is regulated. Like 
other transcript modifications (such as capping and 3’ end processing) there is a known 
correlation between co-transcriptional splicing and CTD modification (Fong and Bentley, 
2001), but the exact interaction with the spliceosome is not known. Some evidence, although 
not definite, points to the recruitment of spliceosome RNPs to the nascent RNA by interaction 
of these with newly synthesized splicing signals and by elongation factors, this last point 
explaining the correlation with the CTD dynamics (Neugebauer, 2002). Evidence also points 
to there being no distinction between splicing of constitutive or alternative exons happening 
co or post transcriptionally, although there seems to be some lag in transcription and splicing 
(Johnson et al., 2000; Pandya-Jones and Black, 2009). In another recent study, spliced 
intermediates were sequenced together with nascent transcripts associated with polymerase in 
yeast, allowing for a new way of studying these events (Churchman and Weissman, 2011). 
Novel approaches are now needed to understand transcription and splicing’s mutual influence.  
 
2.2 3’ end processing and transcription termination 
 
Compared with transcription initiation, less is known about termination. This is in part due 
to difficulties in studying termination, since it requires handling nascent transcripts, and also 
because of some neglect for being a process happening downstream of the encoding region, 
and hence it could be concluded to not have any role in gene expression regulation. 
Termination is characterized by detachment of Pol II from the DNA template, after 
transcription of the polyadenylation (pA) site. Since it was discovered that an intact pA site 
was essential for transcription termination (Connelly and Manly, 1988), evidence for a 
connection between termination and pre-mRNA 3’ end processing - which includes cleavage 
and polyadenylation (CPA) – has been increasing (Proudfoot et al., 2002). 
3’ end processing mechanisms depend on large protein complexes (Shi et al., 2009), with 
elements involved in binding to specific RNA sequences, cleaving the RNA and 
polyadenylation of the new transcript’s generated end. Recognition of the AAUAAA motif, 
which has long been proven to be required for cleavage and polyadenylation (Zarkower et al., 
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1986), is performed by the Cleavage and Polyadenylation Specificity Factor (CPSF), a 
complex with five subunits, including the endonuclease CPSF73. Downstream of this motif, 
the Cleavage stimulation Factor, specifically its subunit CstF64, will bind to a U/GU rich 
motif. These two factors interact with each other through various other elements of the 
complex, ultimately promoting the endonucleolytic activity of CPSF73 between the two 
motifs, 10 to 30 bases downstream of the pA site (Liu et al., 2007; Mandel et al., 2006; Lutz, 
2008). This process and its components are highly conserved in eukaryotes but, despite being 
functionally very relevant, it is interesting to point out that CstF64 has a redundant role, since 
another protein, CstF64τ, is capable of performing the same function. Both proteins are very 
conserved, and seem to have different affinities with their interaction partners, but the 
biological reason for this functional duplication is not still fully understood (Yao et al., 2013).  
In the late 1980’s, two models emerged to explain transcription termination. The allosteric 
model (Logan et al., 1987) postulates that transcription of the pA site leads to conformational 
changes in Pol II or associated elongation factors, which causes dissociation of said factors 
and/or the association of termination factors, leading to 3’ end processing and downstream 
pausing of the polymerase after the release of the downstream transcript. The torpedo model 
(Connely and Manly, 1988) advocates for a termination-dependent degradation of the 
transcript downstream of the cleavage site by an exonuclease (the “torpedo”), later revealed to 
be Xrn2 (West et al., 2004). This enzyme’s activity requires a 5’ entry point, which is 
generated by co-transcriptional cleavage (CoTC), a process in which RNA cleaves itself once 
it is transcribed (Teixeira et al., 2004). However, CoTC activity was only so far identified in a 
small subset of genes (Nojima et al., 2013), making it hard to generalize this mechanism for 
now. But importantly, there is evidence that the two mechanisms may act together, since it 
has been described that cleavage after the pA can happen with Pol II still bound to the 
template, and that degradation by Xrn2 precedes the polymerase release from the template 
(West et al., 2008). This implies that pA site recognition is needed for the success of 
termination, hence pointing to a mixed model. Finally, it is also worth referring that pausing 
after the pA site might also play a role in termination by slowing down the polymerase. 
The above descriptions of transcription termination and 3’ end processing refer to protein-
coding genes in general, but replication-dependent histones are a notable exception. Histones 
are a highly conserved class of proteins responsible for chromatin packing in nucleosomes. 
They are subject to modifications, leading to very diverse roles in transcription regulation. 
Their genes are especially upregulated at the start of the S phase (Stein et al., 2006) because 
of DNA synthesis. Genes coding for replication-dependent histones are typically less than 
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2000 base pairs and intronless. The promoter region of H4 histone gene – the most studied – 
has regulatory sequences unique to other protein-coding genes (Ramsey-Erwing et al., 1994), 
but studies in Drosophila suggest that not all genes from this family are regulated by the same 
factors (Isogai et al., 2007). Similarly to other genes, histone mRNA has a 5’ 7-
methylguanosine cap. However, these transcripts are not polyadenylated, relying instead on 
an exclusive 3’ end processing mechanism. It involves an RNA hairpin formed in the 3’ 
untranslated region (UTR), where a hairpin-binding protein (HBP) binds, so that CPSF73 can 
cleave the pre-mRNA (Dominski et al., 2005). Recognition of the cleavage site and 
positioning of the nuclease is thought to be made by U7 snRNP, which also helps in 
degradation of the 3’ cleaved portion (Cotten et al., 1988). These specificities, and the 
relevance of histones in the cellular context, may translate into particular Pol II dynamics and 
profiles in the synthesis of histone mRNA, not observed in other protein-coding genes. 
The complexity of 3’ processing and termination mechanisms, allied to the co-
transcriptionality and diversity of functions of its components - as shown for CPSF73, but 
also Xrn2, that has a role in premature termination (Brannan et al., 2012) – hints at a link with 
transcription regulatory mechanisms. It can be postulated that Ser2 phosphorylation of the 
CTD, a mark often found at the end of genes, may be related to these processes. An in-depth 
study tracking the polymerase in CPA factors-depleted cells can certainly shine a light on 
mRNA 3’ end determination and effects of the downstream processing events in transcription. 
 
 
3. Micro RNAs 
3.1 Overview 
 
Micro RNAs (miRNA) are RNA strands of about 22 nucleotides that are involved in gene 
expression regulation by transcriptional silencing. They were first discovered in C. elegans in 
1993, when it was described that the gene lin-4 produced a short non-coding RNA with an 
almost complementary sequence to the 3 ’end of the mRNA of lin-14 (Lee et al., 1993). Since 
then, miRNA have been discovered in all superior eukaryotic organisms (Maxwell et al., 
2012). miRNA derive from pre-miRNA, which is an RNA hairpin. 
Regulation by miRNA is preformed through the RNA interference (RNAi) pathway. Their 
function is accomplished together with other proteins in the RNA-induced silencing complex 
(RISC). In the RNAi pathway, pre-miRNA is exported to the cytoplasm via the Exportin 5-
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RanGTP complex (Lund et al., 2004). Upon arriving, the hairpin is cleaved by Dicer, a type 
III RNase, generating a double-strand RNA (dsRNA) of about 22nt (Bernstein et al., 2001). 
Dicer is one of the elements of RISC, the others being HIV-1 transactivation responsive 
element (TAR) RNA-binding protein (TRBP), PACT and proteins of the Argonaut family 
(Rana, 2007). The complex then selects only one of the strands of the dsRNA to be used. The 
selection is not yet fully comprehended, but some evidence points to a selection based on the 
strand thermodynamic stability, discarding the most stable strand (Siomi and Siomi, 2009). 
The complete ribonucleoprotein complex is called miRISC. Finally, the miRNA incorporated 
in RISC will find its target and bind to it. Binding can be partial (only some nucleotides pair 
with the target) or complete. The second is more common in plants, although it can also 
happen in animals. These two mechanisms are functionally different, since incomplete pairing 
only leads to translational silencing (which can be transient), whereas complete pairing leads 
to target mRNA degradation (by the C-terminal PIWI domain of Argonaut proteins), although 
it might not always be the case (Bartel et al., 2004). Many studies point to the pairing of some 
positions having more effect in the mRNA’s fate, rather than the whole miRNA. Additionally, 
in cases of degradation, it has been shown that miRNA can proceed to a different target to 
fulfill the same function (Hutvágner and Zamore, 2002). As for silenced mRNAs, in some 
instances they are clustered in sub-cellular regions called Processing bodies (P-bodies), where 
other interveners may eventually, but not certainly, mediate RNA turnover, generally by 
decapping mRNA (Brengues et al., 2005). 
 
3.2 Micro RNA transcription and processing 
 
As more miRNAs were discovered, it became possible to classify them into distinct 
categories according to their gene structure. Some miRNA are intragenic (Figure 5A), 
whereas others are intergenic (Figures 5B and C). Intragenic micro RNAs are found in 
introns, and usually have the same orientation than the host gene. They can be found in 
introns of protein-coding and long non-coding RNA genes (He et al., 2008). Intergenic 
miRNA can be near or far from other genes. They can be classified into clustered miRNA 
(Figure 5B) or single miRNA (Figure 5C). Micro RNAs belonging to the same cluster can 
have similar functions or related targets, with some clusters being associated with tumors 
(Mendell, 2008). It is thought that all intergenic miRNA have a larger associated transcript 
called primary-miRNA (pri-miRNA), and some were already described, as seen in Figure 5B 
(Lee et al., 2002). Like their intragenic counterparts, most intergenic miRNA are transcribed 
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by Pol II (Lee et al., 2004), although some miRNA clusters, because of their close association 
with Alu elements, are transcribed by RNA polymerase III (Borchert et al., 2006). 
In order to obtain the pre-miRNA, introns (after being debranched) and pri-miRNA have to 
be cleaved so that the hairpin sequence can be obtained. The nuclear RNase III Drosha is 
responsible for the primary transcript cleavage (Lee et al., 2003), acting together with DGCR8 
(Yeom et al., 2006). However, the mechanism Drosha uses for recognizing the cleavage site is 
still very debated (Zeng et al., 2004; Ma et al., 2013), and so prediction of these sites has a 
large value in understanding the mechanism and recognizing novel miRNA (Hu et al., 2013). 
In addition to this, some micro RNAs differ from their reference in very few nucleotides. 
These are called isomiRs (Morin et al., 2008), and although their biogenesis is still poorly 
understood, there is evidence pointing to some of them owing their variability to multiple 
cleavage by Drosha (Ma et al., 2013). 
Just like every type of gene, micro RNAs must also have proper nomenclature for 
organization purposes. In earlier times, naming was more similar to genes, and the 
standardization to include “mir” on their name (still following the formatting for a species 
gene’s name) was only included later (Ambros et al., 2003). Also, miRNAs from the same 
hairpin used to be distinguished by their expression level, but nowadays that is done based on 
strand. Naming also depends on homology with miRNA found in other organisms, on the 
genomic locus they’re included, on base differences between two sequences and on the order 
of discovery (Griffiths-Jones, 2004). Most of the current information about micro RNAs is on 
miRBase (current version is v21, most recent description in Kozomara and Griffiths-Jones, 
2014). This database includes deep sequencing datasets, genomic coordinates, sequence and 
Figure 5: Three distinct types of miRNA genes. A – intronic miRNA; B – Intergenic clustered miRNA; C – intergenic 
single miRNA 
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biological information, among other relevant details. In this database, miRNA are named like 
has-mir-17-5p, where the first three letters describe the species, and 5p tells the strand. When 
new miRNAs are discovered they can be added to the database and the attributed name can be 
then included in the publication. 
 
 
4. Genome-wide study of transcription 
4.1 High-throughput sequencing approaches 
 
Understanding transcription is historically associated with molecular, genetic or 
biochemical studies of single genes or components. The first change in this paradigm came 
with the introduction of microarrays (Schena et al., 1995), allowing for the quantification of 
the RNA from several genes at the same time. With development of the technology, it became 
possible to identify alternative splice sites (Johnson et al., 2003) and to correlate co-
expression of genes with promoter motifs (Veerla and Höglund, 2006). In spite of the huge 
breakthroughs they allowed in gene expression studies, microarrays have some inherent bias 
when it comes to coverage and amplification (Boelens et al., 2007). The development of next 
generation sequencing (NGS) technologies allowed for the development of less biased, albeit 
more expensive, techniques, with greater coverage. RNA-seq was capable of providing the 
same type of information as microarrays, but in an even larger scale, driving the discovery of 
novel transcripts and isoforms. Analyzing cell-fraction RNA-seq data also revealed a 
generalized presence of co-transcriptional splicing in protein-coding genes, but not so much 
in lncRNAs (Tilgner et al., 2012). But because it is a dynamical process, transcription ought 
to be studied using methodologies that focus not only on the end product, the mRNA, but also 
on the intermediates in its synthesis – nascent RNA and Pol II. 
Chromatin immunoprecipitation (ChIP) protocols have been developed to assess 
interactions between proteins and DNA (Kim and Ren, 2006). The binding sites in DNA were 
initially analyzed using microarrays, but quickly became evident that the coverage offered by 
next generation high-throughput sequencing would provide more accurate and robust results, 
which led to the development of ChIP-seq protocols (Johnson et al., 2007; Robertson et al., 
2007). Later, ChIP-seq was used to assess Pol II distribution across genes (Baugh et al., 
2007), which attested the large accumulation of stalled Pol II in a promoter proximal region 
previously described in microarray studies (Kim et al., 2005; Guenther et al., 2007). ChIP-seq 
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assays were also performed using antibodies that specifically target different phosphorylation 
patterns, thus showing a broad genome-wide picture of where in genes each phosphorylation 
mark could be found (Rahl et al., 2010, Grosso et al., 2012). 
While ChIP-seq profiles rendered a good image of gene occupancy by Pol II, resolution 
was still low, there was no distinction of whether the enzyme was actively transcribing or 
paused, and the focus in the relevant part of transcription – RNA synthesis – was not being 
captured. This resulted in the development of four techniques that aimed to solve these 
problems, all of them targeting Pol II-associated RNA (Figure 6).   
Short capped RNA-seq (Nechaev et al., 2010) was introduced to study promoter-proximal 
pausing. It captures RNAs with a 7-methylguanosine cap, selecting those with between 25 
and 120 bp. Those short RNAs are then sequenced, and it is possible to determine the first 
base transcribed - by using a 5’ sequencing primer – or the last base – using a 3’ sequencing 
primer. The last base sequenced is the last base incorporated by the polymerase, so the 
technique allows determination of paused Pol II position at a single-nucleotide resolution by 
aligning the whole reads and then extracting that base. However, this protocol can only 
provide knowledge on the position of paused polymerases in early elongation, because of the 
size and cap selection steps, and it cannot also accuratly distinguish between Pol II associated 
nascent transcripts and released short transcripts. 
The sequencing of native elongating transcripts (NET-seq) associated with Pol II 
(Churchmand and Weissman, 2011) was able to expand the single-nucleotide resolution of 
polymerase tracking to the whole gene. This method is based on the immunoprecipitation of a 
Figure 6: RNA-based genome-wide transcription tracking protocols. Short-capped RNA sequencing selects the target 
RNAs by the presence of a 7-methylguanosine cap; NET-seq selects the RNA attached to the polymerase by 
immunoprecipitaton targeting a synthetic flag; and GRO-seq and PRO-seq are based on in vitro run on reactions using 
labeled nucleotides. Description of each technique in the main text. 
 16 
 
flag-tagged Pol II. Due to the stability of the trenary complex, it is possible to extract the 
RNA associated with the polymerase. Aligning the reads and extracting the position of the 
last base will tell which was the last nucleotide incorporated. The method was also designed 
as strand-specific, giving information about sense and antisense nascent transcripts. This is an 
important distinction as it reduces noise in the data and allows the discovery of new 
transcriptional units. Finally, NET-seq also captures splicing intermedates from co-
transcriptional splicing. While this has to be considered while analyzing the data, it also 
allows the study of splicing, and perhaps other co-transcriptional events that generate 
intermediates, if they’re captured by the protocol. 
Both of the methods described above unbiasedly capture Pol II-associated transcripts. But 
they make no distinction of which polymerases are paused or actively engaged in 
transcription. Acquiring the position of engaged Pol II can be achieved through nuclear run-
on reactions coupled to sequencing, as it is done in global run-on sequencing (GRO-seq) and 
precise run-on sequencing (PRO-seq) (Core et al., 2008; Kwak et al., 2013). The first method 
uses Br-UTP to mark the run-on synthesized transcripts so they can be isolated and then 
sequenced. Yet this method lacks precision when compared to the others described, so it was 
upgraded to PRO-seq. In this protocol, four libraries are prepared from four run-on reactions, 
each of them using only one nucleotide as substrate. The nucleotides used are biotinylated so 
that the transcripts can be selected. The libraries are then sequenced and merged, and the last 
base of each read is considered the position where the engaged Pol II is. This method does not 
guarantee single nucleotide resolution as it is possible to find the same nucleotide repeated, 
which would drive the incorporation of two nucleotides in the nuclear run-on reaction. Also, 
the added manipulation required for isolation of nuclei and run-on may also disrupt some 
features of transcription. 
Even though these genome-wide protocols show data for virtually all the genes in the 
genome, there are still biases that need to be considered when presenting the results for these 
experiments. First of all, the protocols are designed to be preformed in a collection of cells. 
While this captures the biological variability between individuals, it does not express exactly 
how a single individual behaves. Specifically, when looking at a single-nucleotide resolution 
gene profile, we may identify two consecutive bases with signal, yet it is physically 
impossible to have two polymerases in consecutive bases. Development of single-cell 
protocols will bring this individuality to the analysis, but conversely sacrificing the patterns 
only observable when looking to many subjects. Second, it is customary to look at metagene 
profiles (i.e. a global average profile for all genes) when interpreting this kind of data. While 
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it may be informative of general features, it may be necessary to subset the genes by some 
feature, and ultimately look at many individual genes, so as to identify differences between 
them that may be lost while averaging the full set. Finally, a constant adaptation of 
computational biology’s protocols and tools is needed, as more advanced and singular arise. 
While some steps in the pipelines are well established, especially alignments, other steps are 
specifically adapted to the protocol in question and may therefore not be fully optimized. 
 
4.2 Data Analysis 
 
The exponential increase of available biological datasets from high-throughput techniques 
– and, in particular, NGS protocols – has stimulated the development of bioinformatical tools 
that can accurately, but also efficiently, process the large volumes of data produced. These 
datasets are not only abundant, but also diverse, as all biological research fields have realized 
the importance of more comprehensive data, rather than focusing on individual components 
of the system studied. This led to the development of many protocols, like the ones described 
in the previous section, to which the data analysis must adapt. 
Although the output of sequencing platforms can differ between them, the most common 
type of files – and the one used in this project - is FASTQ (Cock et al., 2010). In this kind of 
files, each read is named uniquely and accompanied by the quality of each base. It is 
important to know what is the encoding for the quality scores, since some tools do not 
automatically recognize it. Read quality should also be assessed before starting any analysis, 
to account for possible biases. A commonly used tool that collects relevant quality statistics is 
fastqc (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/, last accessed on August 
23rd 2014). This allows the identification of overrepresented sequences, such as adapters or 
RNA sequences that either hinder the analysis or introduce bias, leading to wrong 
conclusions. 
There is a plethora of adaptor trimming tools to choose from. The choice varies with read 
type and size, as well as features offered by each software. Cutadapt (Martin, 2011) is one of 
these tools, and it allows the user to trim reads from both ends and considering as many 
adapter sequences as needed. Besides, it does not require the complete identification of the 
adaptor to perform trimming, allowing the user to set a minimum of nucleotides 
corresponding to the adapter to be trimmed with a certain error rate. When sequencing short 
nucleotide strands using a pair-end protocol, it is possible that the read size is greater than the 
actual length of what is being sequenced. In this case, a variable number of bases 
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corresponding to the opposite strand’s adaptor might be sequenced, resulting in a read that 
cannot be aligned with the reference genome. The referred features offered by Cutadapt 
present a way to solving this issue. 
Aligning the obtained reads to a reference genome is arguably the most important step in a 
sequencing analysis. However, it is usually also the most computationally demanding stage, 
even more considering the need of high coverage data. This happens because of the elevated 
number of comparisons that would have to be made between the bases of millions of reads 
and the billions of bases in a genome, and even more considering the quality of each base. 
Luckily, it is possible to implement some heuristics in order to speed up the algorithms. Many 
aligners have been developed over the years, with the purpose of finding the best balance 
between an accurate alignment and a fast execution. TopHat2 (Kim et al., 2013) is the latest 
version of a widely-used tool for aligning RNA-derived reads to reference genomes. TopHat2 
resorts to Bowtie2, a tool from the same lab (Langmead and Salzberg, 2012), to align the 
reads, and then performs splice junction finding. Many parameters are customizable so that 
the user can fit them to the data. It is usually important to get uniquely aligned reads, as 
multiple aligned RNA reads cannot be interpreted as a product of a single DNA sequence 
transcription. 
TopHat2 outputs a BAM file with information about where the reads aligned to the 
reference. It is a useful way of storing the alignment, but cannot be directly worked with. To 
work with BAM files (and their non-binary counterpart, SAM files), SAMtools is available 
(Li et al., 2009). This collection of tools enables visualization, filtering, sorting and indexing 
of these files, among other features. They can also be used together with other tools to find 
spliced reads, or to isolate the last nucleotide as single-nucleotide resolution techniques 
require. However, BAM and SAM formats do not supply appropriated data that can be 
worked on, such as read counts in genome intervals, and also don’t provide effective means to 
make operations in the data, like intersections or subtractions. For these cases, BEDTools 
(Quinlan and Hall, 2010) come in handy. This toolkit, that relies mostly on the BED format 
(Kent et al., 2002), provides the user with a framework for intersecting datasets, separating 
data by location, calculating local or genome-wide coverage, and can be articulated with other 
tools if needed. The output BED format files are fairly more readable than the SAM format 
ones, and information can be easily extracted to be processed. BEDTools is also compliant 
with other file formats, such as GTF of BAM files, which makes the analysis much more agile 
since there is no need of converting these files to another format. For instance, a BAM file 
output by an aligner may be directly used to assess coverage of desired features. 
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Visualization is of great importance when dealing with genomic data. The UCSC Genome 
Browser (Kent et al., 2002) is a useful online resource for visualizing data in a genomic 
context. It provides several tracks of annotations or data from other sources, so as to facilitate 
interpretation. It is possible to see, gene by gene, the presence of RNA-seq reads or 
polymerase distribution. But to get a sense of what is happening in the average gene, data can 
be compiled in metagene profiles. These profiles divide genes in windows, and plot the mean 
read counts - or a normalized version like reads per kilobase per million reads (RPKM) – of 
every window of all genes. This results in an average profile that makes it possible to identify 
features present in many genes, for instance the accumulation of polymerase in the promoter 
region (Core et al., 2008; Nechaev et al., 2010). However, construction and interpretation of 
these must be done carefully. First, not all genes can be included in a profile. Many genes 
overlap each other, and that can give rise to features that may not exist. Other sets of genes 
may also have their unique features - for example, replication-dependent histones, which are 
shorter than average genes and have unique Pol II occupation profiles -, and so should be 
removed from the analysis. Second, genes can also have unique features that are not displayed 
or that interfere with the profile, and therefore some manual selection of the genes included 
has to be preformed, and individual examples should always be shown. Other metrics can be 
presented to highlight differences between sets of genes or conditions. A logarithm of the 
quotient of the number of reads in two windows is a useful means for making such 
comparisons, and a distribution of the values for the genes can also be shown as a boxplot. 
Further statistical testing can be applied to confirm those differences. 
From an RNA-seq experiment we can also identify which transcript isoforms are more or 
less expressed. The Cufflinks software (Trapnell et al., 2010) is widely used as a tool to 
attribute read counts to genes and isoforms, allowing inferences to be made about their 
expression. But it is also possible to identify which exons are alternatively being expressed. 
MISO (Mixture-of-Isoforms) (Katz et al., 2010) uses RNA-seq data to quantitatively predict 
which alternative splicing phenomena occur in a sample or between samples. This program 
uses its own database of alternative splicing events, and follows a Bayesian framework to 
attribute a read either to one isoform or another. The database are divided by their type of 
event (skipped exons, alternative 3’/5’ splice sites, mutually exclusive exons, tandem 3’ 
UTRs, retained introns, and alternative first or last exons), and processing results in a value 
that indicates whether one event or the other is selected. For instance, in a larger scale, this 
allows seeing differences between included or skipped exons in polymerase occupation, but 
these and other features can also be shown individually. 
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NGS technologies opened the door to large genomic studies, and to high coverage 
sequencing data. Yet, constant adaptation of methodologies is required for capturing not only 
the broad patterns but also the fine details provided by these approaches. 
  
5. Objectives 
 
Considering the complexities of RNA transcription and processing, this work aims to 
elucidate more about the interactions between these two processes in a genome-wide scope. 
The focus of this study is the Pol II CTD, since it is one of the key regulators of interactions 
involving Pol II during transcription. To achieve this, the NET-seq protocol (Churchman and 
Weissman, 2012) was modified to enable usage of CTD isoform-specific antibodies. An 
additional step was also included where the chromatin fraction from which Pol II was 
precipitated was treated with micrococcal nuclease (MNase), in order to degrade exposed 
RNA sequences, thus increasing the specificity for RNA protected by Pol II. This new 
protocol was termed “advanced NET-seq” (ANET-seq), and allows for the first time for a 
single-nucleotide resolution mapping of CTD isoforms in the genome. To further support 
ANET-seq results and interpretation, chromatin-fraction RNA (ChrRNA) was sequenced. 
This would show some unstable RNAs, such as promoter upstream transcripts (PROMPTs) 
introns, and transcription downstream of the 3’ end. All samples were sequenced in Illumina 
HiSeq 2000 or 2500 sequencers. 
Two sets of data were produced for this project. The first includes one ChrRNA sample 
and ANET-seq samples generated using antibodies for unphosphorylated Pol II CTD, Ser2-
phosphorylated CTD, Ser5-phosphorylated CTD and all CTD isoforms. These aimed at 
showing differences between CTD isoforms in transcription. The second includes ChrRNA 
and ANET data from three 3’ end processing and termination factors knock-downs and a 
control. These are meant to show the effects that each factor has on Pol II transcription 
dynamics and changes in newly synthesized transcripts. The ANET-seq from this set used an 
antibody targeting Ser2-phosphorylated CTD, the predominant isoform at the end of genes. 
 
The main objectives of this project were: 
1. Define an analysis pipeline for ANET-seq data. 
2. Comprehend the roles of different CTD isoforms in during transcription. 
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3. Examine the CTD phosphorylation dynamics associated with splicing and 
miRNA biogenesis. 
4. Elucidate the different roles of the termination factors Xrn2, CPSF73 and 
CstF64+CstF64τ during transcription. 
 
Being a frontier discipline, computational biology requires the input and collaboration 
specialists from different fields. It is from the combination of these different skill sets that 
complex and relevant new discoveries can be made. In this work, I preformed all of the 
sequencing data analysis, such as trimming and aligning reads, making average gene and exon 
profiles, plotting single gene profiles or calculating Escaping Indices. The experimental work 
was performed by other scientists specialized in those protocols and they are duly credited in 
the final manuscript. 
The funding for the work here presented was granted by Wellcome Trust Programme, ERC 
Advanced Grants and Fundação Ciência e Tecnologia. 
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1. Summary 
 
RNA polymerase II (Pol II) transcribes nascent RNA throughout the mammalian genome. 
However, many aspects of nascent RNA metabolism are poorly understood due to RNA 
instability and technical limitations. We have employed high throughput sequencing at single-
nucleotide resolution to characterize nascent transcription in HeLa cells; advanced native 
elongating transcript-sequencing (ANET-seq). This provides precise maps of nascent RNA 
within the Pol II elongation complex that correlate with the C-terminal domain (CTD) 
phosphorylation state of the Pol II large subunit. We detect substantial Pol II bidirectional 
pausing at transcription start sites (TSS). We also demonstrate exon tethering to the CTD Ser
5
 
phosphorylated Pol II complex and co-transcriptional pre-miRNA biogenesis. Depletion of 
cleavage and polyadenylation (CPA) factors causes termination defects, reducing Pol II 
pausing at transcription end site (TES). Additionally the 3' end termination machinery plays a 
promoter role by restricting non-productive RNA synthesis at the TSS in both sense and 
antisense directions. 
(150 words) 
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2. Highlights  
 
 ANET-seq monitors nascent RNA within the mammalian Pol II complex. 
 Pol II pausing at TSS and TES with different Pol II CTD phosphorylation states. 
 Exon tethering during co-transcriptional splicing links CTD S5P to 5’SS cleavage.  
 Diverse kinetics of co-transcriptional pre-miRNA biogenesis. 
 CPA factors are associated with Pol II pausing at TES. 
 CPA factors and Xrn2 regulate sense and antisense premature termination at TSS. 
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3. Introduction 
 
The global analysis of nascent RNA has been achieved by genome-wide nuclear run on-
sequencing (GRO-seq) and precision nuclear run on-sequencing (PRO-seq) using modified 
nucleotides (Core et al., 2008; Kwak et al., 2013). These approaches have provided high 
resolution maps of Pol II nascent transcription in mammals and flies. In both cases, Pol II 
accumulation was detected at promoters where it acts as a major regulatory block in the 
transition into productive transcriptional elongation (Core et al., 2008; Hah et al., 2011; Min 
et al., 2011; Rahl et al., 2010; Saunders et al., 2006). The precise maps of PRO-seq reads 
identified two different types of Pol II pausing at the transcription start site (TSS), referred to 
as proximal and distal TSS pausing. PRO-seq additionally showed Pol II accumulation near 3' 
splice sites (SS) which is likely to be important for the selection of active exons (Kwak et al., 
2013). The GRO-seq approach has also provided a correlation between Pol II density and 
nucleosome occupancy as observed at the 3' end of many genes (TES, transcription end site), 
suggesting a connection with transcription termination (Grosso et al., 2012). 
Precise maps of Pol II nascent RNA have also been generated by the native elongating 
transcript-sequencing (NET-seq) method in yeast (Churchman and Weissman, 2011). Here 
endogenous Pol II was flag tagged by genomic integration which allows the Pol II nascent 
RNA complexes to be immuno-precipitated with flag antibody. This method revealed that Pol 
II back-tracks during elongation, based on single nucleotide resolution of nascent RNA 
profiles. However, the relationship between Pol II CTD modifications and nascent RNA could 
not be determined. We now report the establishment of a modified mammalian NET-seq 
technique using a selection of CTD modification specific Pol II antibodies. We use this 
technology to monitor genome-wide nascent RNA profiles in HeLa cells and call this 
technology advanced NET-seq (ANET-seq). Importantly, we correlate different Pol II CTD 
modifications with specific patterns of nascent transcription and coupled RNA processing. 
Our extensive ANET-seq datasets (obtained using different CTD modification specific Pol II 
antibodies) provide a “treasure trove” of detailed information on co-transcriptional RNA 
processing in mammalian cells. In this study we have focused on protein coding gene 
transcripts. Future analysis will turn to intergenic non coding (nc) RNA transcription.  
It is widely known that Pol II CTD is differentially phosphorylated during the 
transcription cycle. CTD comprises a 52 repeated heptapeptide (Tyr
1
-Ser
2
-Pro
3
-Thr
4
-Ser
5
-
Pro
6
-Ser
7, 
YSPTSPS) which is highly phosphorylated during productive transcription. Based 
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on chromatin immuno-precipitation (ChIP), Ser
5
 phosphorylation (S5P) accumulates at active 
promoters while Ser
2
 phosphorylation (S2P) is involved in co-transcriptional processing 
events in the gene body, such as splicing and 3' cleavage and polyadenylation (CPA) (Brookes 
and Pombo, 2009; Egloff et al., 2012a; Heidemann et al., 2013). We used unphosphorylated 
(unph), S2P, S5P and total (unph+ph) CTD antibodies to analyze CTD phosphorylation-
specific nascent RNA profiles across the human genome. ANET-seq analysis reveals that 
unph CTD Pol II-nascent RNAs are accumulated over the TSS while S2P Pol II nascent RNA 
are spread throughout the gene body and TES, demonstrating that this method provides 
differential maps of CTD phosphorylation-specific nascent RNA. Interestingly, high CTD S5P 
Pol II associated signals are detected at 3' ends of functional exons. We have also 
characterized co-transcriptional microprocessing of pre-miRNA in the introns of protein 
coding genes and describe new features of this mechanism. Although Pol II pausing at TES is 
well established (Davidson et al., 2014; Proudfoot, 2011; Skourti-Stathaki et al., 2011), CPA 
factors are also recruited co-transcriptionally onto chromatin (Glover-Cutter et al., 2008), but 
their effect on Pol II pausing has not been widely characterized. Our ANET-seq data show that 
depletion of CPA factors such as CPSF73 and CstF-64+CstF-64 tau proteins cause a 
substantial reduction of Pol II pausing downstream of TES. In contrast 5'-3' exonuclease Xrn2 
knockdown did not affect TES pausing. Surprisingly depletion of all of these 3' end 
termination factors increases promoter-associated CTD S2P Pol II pausing on both mRNA 
and promoter upstream transcript (PROMPT) strands.  
It is abundantly clear that ANET-seq can be used to generate precise maps of Pol II 
phosphorylation-dependent nascent RNA profiles across the human genome. We predict that 
ANET-seq will be a powerful tool to demystify the complexities of Pol II pausing and co-
transcriptional RNA processing. 
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4. Results 
4.1 ANET-seq strategy 
As a starting point to enrich for unstable nascent RNA across the human genome, we 
isolated a nuclear chromatin fraction which is enriched in the transcriptionally active Pol II 
isoform (Pol IIo) and associated nascent RNA (Figure S1; (Nojima et al., 2013; West et al., 
2008). This chromatin-bound RNA was directly sequenced (ChrRNA-seq) as follows. RNA 
was fragmented to 150~200 nt and ligated to adaptors for strand-specific paired end deep 
sequencing (Figure 1A top and Experimental Procedures). ChrRNA-seq detects unstable RNA 
such as promoter upstream transcripts (PROMPTs), introns and read through transcripts 
(Figure 1D). For ANET-seq, the chromatin fraction was independently subjected to Pol II 
immuno-precipitation (IP) so that nascent RNA could be correlated with Pol II genic 
distribution. In detail chromatin was first digested with micrococcal nuclease (MNase) prior 
to Pol II IP. Note that accessible RNA will also be digested by MNase treatment (Figure 1A 
bottom and Figure S2). To confirm that Pol II is effectively released from the insoluble 
chromatin fraction, western blot analysis was carried out on the supernatant fraction using Pol 
II 8WG16 antibody. Both phosphorylated (Pol IIo) and unphosphorylated (Pol IIa) forms were 
detected in a MNase dose-dependent manner (Figure 1B). IP was then carried out on the 
supernatant derived from MNase-digested chromatin using Pol II 8WG16 antibody (Figure 
1C). To check nascent RNA distribution after the cell fractionation and MNase digestion, we 
initially used nuclei that had been subjected to nuclear run on (NRO) labeling with [-32P] 
UTP. In the nucleoplasmic (Np) fraction, radiolabeled long RNA (over 600 nt) was detected. 
After MNase incubation, a smear of RNA (10-600 nt) was detected in the chromatin pellet 
(P), but a shorter RNA smear (10-200 nt) in the chromatin supernatant (S). As expected, these 
shorter RNAs were efficiently precipitated by Pol II 8WG16 antibody. Although the 
predominant size of the immuno-precipitated RNA was 20-45 nt, we selected a longer RNA 
fraction (35-100 nt) to obtain uniquely mapable reads on the human genome following deep 
sequencing. In this method, the Pol II complex will protect nascent RNA from MNase 
digestion. The hydroxylated 3' end (3’OH) of the nascent RNA corresponds to the terminal 
nucleotide synthesized by Pol II (shown by an asterisk in Figure 1A). The 5' end of the 
cleaved Pol II-associated RNA will also be hydroxylated after MNase digestion. To achieve 
strand-specific RNA sequencing we carried out a kinase reaction on the IP beads to 
phosphorylate all nascent RNA 5’ ends but leaving the 3’OH intact (Figure S2). We then 
ligated Illumina adapters to gel purified RNAs and performed Illumina High throughput  
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Figure 1. ANET-seq methodology
(A) ChrRNA-seq and ANET-seq strategies. Pol II (dark blue) elongation complex (light blue circle) and 
associated nascent RNA (red line) was purified from chromatin for ChrRNA-seq (top). Orange asterisk 
shows catalytic site in Pol II. Fragmented nascent RNA was subjected to directional paired-end deep 
sequencing. For ANET-seq (bottom), DNA and RNA were digested with MNase and the Pol II-nascent 
RNA complex was precipitated with different Pol II antibodies. Isolated RNA was 3’ end deep 
sequenced and the 3' end nucleotide uniquely mapped on the human genome (green bars).
(B) Pol II release from insoluble chromatin DNA. Chromatin DNA was digested with indicated concentration 
of MNase. Western blot was carried out using 8WG16 Pol II antibody. P; pellet, S; supernatant.
(C) Nascent RNA distribution in ANET-seq method. Nascent RNAs were 32P-labeled by NRO reaction. 
Fractionated nascent RNA were from Nucleoplasm (Np), Chromatin pellet (Chr (P)) and supernatant 
(Chr (S)). IP was with 8WG16 Pol II antibody. 35-100 nt RNA purified from gel (red box).
(D) ATP5G1 gene ANET-seq. Two biological replicates of ANET-seq/unph using 8WG16 Pol II antibody. 
ChrRNA-seq shown as ANET-seq input. ChIP-seq (Pol II (unph), H3K4m3 and H3K36m3) data are from 
ENCODE project datasets (Consortium et al., 2012).
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paired-end sequencing which generated ~10
8
 reads for each ANET-seq sample. For library 
construction we omitted the NRO step since the NRO reaction disturbs the native Pol II 
distribution (data not shown). The above Pol II IP from MNase treated chromatin, isolation 
and sequencing of the associated RNA constitutes a refined mammalian NET-seq protocol that 
we term ANET-seq. 
Finally, libraries were prepared from two biological replicates of HeLa native chromatin 
after Pol II 8WG16 IP. Deep sequencing was conducted using a reverse sequence primer to 
read the 3' ends of the RNA insert which corresponds to the RNA synthesis site in the Pol II 
active site (Figure 1A). ANET-seq data aligned to the human genome (hg19) was compared to 
8WG16 Chromatin IP (ChIP)-seq and ChrRNA-seq in either transcriptionally active or 
inactive genes (Figure 1D). Modifications of Histone H3, H3K4m3 and H3K36m3, reflect 
active promoters and gene bodies, respectively. Strand-specific transcription activity was 
revealed by ChrRNA-seq. As expected, both replicates of ANET-seq/8WG16 (unph) display 
strong peaks at the active TSS consistent with the ChIP-seq/8WG16 (unph) profile. 
Additionally, ANET-seq data revealed both sense and antisense transcription on active genes, 
as previously shown by GRO-seq and PRO-seq (Core et al., 2008; Kwak et al., 2013). Note 
that ChIP-seq is not able to distinguish the strand-specific Pol II distribution. 
 
4.2 Pol II CTD phosphorylation-specific nascent RNA profiles at TSS and TES 
A major benefit of ANET-seq is that it allows the use of different Pol II antibodies to 
precipitate modified Pol II-associated nascent transcripts. We therefore used specific 
monoclonal antibodies to detect CTD phosphorylation-dependent nascent RNA profiles. The 
newly described CMA302, CMA303 and CMA301 mouse monoclonal antibodies are specific 
for CTD S2P, CTD S5P and all CTD isoforms respectively (Stasevich et al., 2014). 8WG16 is 
known to be relatively selective for unphosphorylated CTD. By way of confirmation we show 
IP Pol II western blots using these antibodies under ANET-seq conditions (Figure 2A). 
Although CMA302 antibody is able to precipitate some Pol IIa, both of CMA302 and 
CMA303 antibodies mainly recognize Pol IIo (Figure 2B). As expected 8WG16 antibody 
precipitated mainly Pol IIa. We also performed Pol II ChIP analysis on three specific genes 
using these monoclonal antibodies and compared them to the commercial polyclonal 
antibodies (ab5095 (S2P) and ab5131 (S5P), respectively) which are widely used for ChIP-
seq assay (Perez-Lluch et al., 2011) (Figure S3). Notably very similar ChIP profiles were 
observed for the different S2P and S5P specific antibodies. 
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Based on previously published RNA-seq data (Lacoste et al., 2014) , we found 11,560 
(45%) of RefSeq genes are actively transcribed in our HeLa cell line. However to avoid noise 
caused by over-represented sequences from ncRNA (such as rRNA, tRNA, snoRNA and 
snRNA) in the ANET-seq metagene analysis, we excluded genes that overlap with these 
sequences. We also excluded overlapping gene transcription units as these might give 
bioinformatic bias such as pseudo-antisense transcripts from neighboring genes in the TES    
(Figure S4A). Finally we selected only isolated genes that have no other transcription unit 
within -1 kb of the TSS or +3 kb of TES (Figure S4B). We were therefore left with 1,647 
protein-coding genes to study in metagene analyses of our ANET-seq data (Figure S4C). 
These data reveal striking differences between the four different antibody IPs used in our 
ANET-seq analysis. 8WG16 and CMA301 (ANET-seq/unph and ANET-seq/unph+ph, 
respectively) display substantial bidirectional (sense and antisense) peaks at the TSS. 
However CMA302 and CMA303 (ANET-seq/S2P and ANET-seq/S5P, respectively) show 
lower TSS peaks (Figure 2C and 2D). In contrast ANET-seq/S2P gives more signal at TES 
than ANET-seq/unph and ANET-seq/S5P (Figure 2C and 2E), consistent with the gene 
specific ChIP profiles (Figure S3). Unexpectedly, ANET-seq/S5P does not display a major 
TSS peak in contrast to previously published Pol II S5P ChIP profiles (Heidemann et al., 
2013). 
 
4.3 Exon tethering to Pol II S5P for co-transcriptional splicing 
The coupling of Pol II transcription to splicing is now well established (David and Manley, 
2011; Moore and Proudfoot, 2009). Thus phosphorylated Pol II CTD (S2P) recruits splicing 
factors to enhance pre-mRNA splicing efficiency (Ahn et al., 2004; Hirose and Manley, 
1998). Also altered Pol II elongation speed can affect alternative splicing patterns (Ip et al.,  
Figure 2. ANET-seq with different Pol II modifications 
(A) Diagram showing different Pol II antibody epitopes on CTD (Stasevich et al., 2014).  
(B) Pol II precipitated from cell extracts with indicated antibodies detected by western blot using each antibody. 
(C) Metagene analyses of ANET-seq on TSS and TES. Read density (RPKM) of ANET-seq databases was plotted around 
TSS (+/- 1 kb) and TES (-0.5k~+3 kb). Metagene of ChrRNA-seq is shown as input. Each metagene has different scales on 
y-axis. Data are represented as mean +/- SE from 1,647 genes. 
(D) ANET-seq profiles on TSS of TAF1 gene. Read density; read per 108 sequences. Each ANET-seq has different y-axis 
scale. 
(E) CDK1 gene ANET-seq profiles at TES. All ANET-seq data are shown on same y-axis scale. 
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2011; Kornblihtt et al., 2004; Munoz et al., 2009). This is taken to indicate that Pol II slows 
down near splice sites (SS) to promote spliceosome assembly. In particular genome-wide 
analysis of nascent RNA by high-resolution tiling arrays in yeast has shown that Pol II is 
paused over terminal exons, but only for co-transcriptionally spliced genes (Carrillo 
Oesterreich et al., 2010). Additionally, precisely timed ChIP analysis in yeast showed that 
phosphorylated Pol II (S5P CTD) accumulates over the 3' SS of intron containing genes. 
Furthermore this splicing-dependent Pol II pausing requires pre-spliceosome assembly 
(Alexander et al., 2010; Chathoth et al., 2014). 
We were interested to determine if our ANET-seq profiles reflect the co-transcriptionality 
of splicing but observed unexpected patterns. First we present the ANET-seq profile of a 
specific gene, TARS where we have compared its ANET-seq profiles between the four 
different Pol II antibodies (Figure 3A). Surprisingly, ANET-seq/S5P in particular detected 
prominent peaks in gene exons. We have reasoned that ANET-seq will specifically identify 
the nascent transcript 3’OH in the Pol II active site. However as previously noted (Churchman 
and Weissman, 2011) co-precipitated spliceosomes will also contain 3’OH RNA derived from 
intermediates in the splicing reaction. These 3’OH will potentially yield ANET-seq signal. 
Remarkably, ANET-seq/S5P on the PAPD7 gene yields peaks that are exactly located at exon 
3’ ends (Figure 3B). These observations suggest that ANET-seq/S5P detects the 5’SS cleavage 
splicing intermediate. This indicates that spliceosome complex C is directly associated with 
Pol II CTD S5P. To extend these observations we performed metagene analyses on exons that 
are either included or excluded in the mature mRNA, looking 50 nt upstream or downstream 
of exons. Notably the ANET-seq data shows a strong S5P specific peak at the 5’SS of 
included but not excluded exons. (Figure 3C-F). This result confirms that the ANET-seq 5’SS 
Figure 3. Exon tethering to Ser5-phosphorylated Pol II complex 
(A) TARS ANET-seq profile with different antibodies. S5P-dominant peaks are indicated by orange arrows.  
(B) Co-transcriptional splicing model. 3'OH of upstream exon (UpEx, dark red). RNA and catalytic site in Pol II are 
shown as red and black asterisks. 3' OH of the UpEX RNA is protected in S5P Pol II (red)-spliceosome C complex 
(purple circle) and mapped at 3’ ends of PAPD7 exons 9, 10 and 11 in two independent replicates of ANET-seq/S5P data. 
(C and D) Metagene of ANET-seq data over 5’ ends (3’SS) of included (spliced) exons (C, orange rectangle) and 
excluded exons (D, green rectangle). 
(E and F) Metagene of ANET-seq data around 3’ ends (5' SS) of included exons (C, orange rectangle) and excluded 
exons (D, green rectangle). Data are mean +/- SE from 3,115 and 304 genes for excluded and included exons. 
(G) PKM exons 8-11 are illustrated. Exon 9 (green) and exon10 (orange) are mutually exclusive. PCR primers indicated. 
RT-PCR products were digested with indicated exon-specific restriction enzyme (NcoI or PstI). 
(H) ANET-seq data around mutually exclusive exons 9 and 10 of PKM. ANET-seq/S5P signals at 3' end of exon 9 and 
exon 10 are shown by green and orange arrows. 
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signals derive from active splicing. We also studied the alternatively spliced (mutually 
exclusive) exon 9 and 10 of PKM. RT-PCR and ChrRNA-seq analyses show that exon 10 is 
predominantly included in mature PKM transcripts in HeLa cells (Figure 3G) (David et al., 
2010). ANET-seq/S5P signals are largely accumulated at 3' end of exon 10 of PKM (Figure 
3H). Together with metagene analyses, these results strongly suggest that spliceosomes are 
tethered to Pol II to promote co-transcriptional splicing. Remarkably, this first splicing step is 
specific to Pol II CTD S5P.  
 
4.4 Co-transcriptional pre-miRNA biogenesis 
Most pre-microRNAs (miRNA) are present within the introns of protein coding genes, 
where they are excised co-transcriptionally by the microprocessor complex, containing 
Drosha and DGCR8 (Morlando et al., 2008; Pawlicki and Steitz, 2008). Drosha cleavage 
generates 3’OH ends which have the potential for detection by ANET-seq. Since RNA 
cleavage sites on pre-miRNA generated by the microprocessor complex are highly variable, 
we individually checked the ANET-seq profiles for each pri-miRNA that is highly expressed 
in HeLa cells. We detect two peaks defining the pre-miRNA 5' and 3' ends for intronic hsa-
mir-27b where the 3' peak is dominant. In contrast for intronic hsa-let-7g, the 5' peak is 
dominant (Figure 4A and 4B). Additionally we often observe a single 5' peak of ANET-seq for 
pre-miRNA sequences such as hsa-miR26b (Figure 4C). Interestingly, 5' end and 3' end peaks 
correspond to the 3' ends of the cleaved intron and the pre-miRNA which reaffirms the co-
transcriptionality of pre-miRNA processing. As with spliceosomes we suggest that that 
microprocessor is co-precipitated with Pol II so that 3’OH intermediates of Drosha cleavage 
are detected by ANET-seq. 
Two pre-miRNAs (hsa-mir181a-1 and hsa-mir181b-1) are located in the MIR181A1HG 
intron (Figure 4D). Although ENCODE Project (Consortium et al., 2012) shows both mature 
miRNAs are expressed in HeLa cells, only hsa-mir181a-1 yields significant ANET-seq peaks.  
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This correlates with ChrRNA-seq analysis showing a signal window over has-mir181a-1 
but not b-1. We infer that only a-1 is co-transcriptionally processed. Evidently ANET-seq can 
be used to distinguish co-transcriptional and post-transcriptional pre-miRNA processing. We 
also note that the variable ANET-seq double peaks (i.e. hsa-mir-27b) and single peaks (i.e. 
hsa-mir-26b) suggest kinetic differences in pre-miRNA biogenesis. Some pre-miRNAs (such 
as pre-miRNA-26b and 181a-1) may be released immediately from the Pol II elongation 
complex after microprocessor cleavage (see model, Figure 4E). Other pre-miRNAs (such as 
pre-miRNA-27b and let-7g) may be more slowly released with the 3' ends of the pre-miRNA 
still tethered to the Pol II elongation complex. Significantly ANET-seq/S2P and S5P show 
larger peaks than ANET-seq/unph for pre-miRNA processing suggesting that CTD 
phosphorylation is important for co-transcriptional pre-miRNA biogenesis. 
Four additional examples of pre-miRNA containing loci (Figure S5) emphasize the 
generality of our ANET-seq data. For MIR17HG locus containing six tandem pre-miRNA 
(Figure S5B) Drosha co-transcriptionally cleaves the outer pre-miRNA. However more inner 
pre-miR18a and pre-miR19a appear to be processed post-transcriptionally as judged by a lack 
of ANET-seq peaks and the absence of a hole in the ChrRNA-seq profile over these 
sequences. 
 
4.5 Pol II pausing regulated by CPA factors at TES 
Depletion of CPA factors (CPSF73 and CstF-64+CstF-64 tau) and Xrn2 proteins was 
performed by siRNA transfection and the protein level reductions were monitored by western 
blot using the indicated antibodies (Figure 5A-C, left panels). ChrRNA-seq analyses (both for 
specific genes and by metagene analysis) demonstrated clear Pol II termination defects 
following depletion of CPA factors (Figure 5A and 5B) We note that double-knockdown of 
CstF-64 and CstF-64 tau proteins was necessary to detect termination defects due to the 
functional redundancy in HeLa cells (Yao et al., 2012). Xrn2 knockdown showed no 
termination defect at protein-coding gene TES (Figure 5C) as suggested previously (Brannan  
Figure 4. Pre-miRNA biogenesis from protein coding gene introns 
(A-D) ANET-seq with different Pol II antibodies versus ChrRNA-seq over intronic pre-miRNAs, hsa-mir-27b (A), hsa-let-
7g (B), hsa-mir-26b (C) and hsa-mir181a/b-1 (D) denoted by black rectangles. Frequent RNA cleavage sites identified by 
orange arrows and dashed lines. Small RNA-seq data are shown at bottom (green). 
(E) Model of co-transcriptional pre-miRNA biogenesis. UpEx, DwEx and pre-miRNA DNA sequences in red, orange and 
grey. Co-transcriptional RNA cleavage by microprocessor and spliceosome (light blue) shown with 3' end of cleaved RNA 
and pre-miRNA tethered to phosphorylated CTD. Pre-miRNA release may occur from the transcription complex, fast 
(dark red arrow) or slow (blue arrows). Finally 5'SS is spliced to 3'SS in spliceosome. Curved arrow denotes exon splicing. 
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Figure 5. ChrRNA-seq reveals CPA knockdown causes TES termination defect 
(A-C) Western blots showing knockdown efficiencies of siRNA treatments for CPSF73, CstF64/Tau and Xrn2. Aly and Tubulin proteins 
are loading controls (A) Termination defect detected following depletion of CPSF73 protein (red) on GAPDH gene and metagene profile 
over TES. n=1,647 (B) Additive termination defect seen following double knockdown of CstF64 and CstFTau (turquoise and blue and 
dark blue double) on PGM1 and metagene profile over TES. n=1,647. (C) No termination defect detected following Xrn2 depletion 
(green) on ACTB and metagene profile over TES. n=1,647.
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et al., 2012). Possibly like CstF64 this factor acts redundantly with other termination 
factors. Interestingly Xrn2 depletion substantially increased transcript levels within the gene 
body suggesting a major role for Xrn2 in nuclear turnover (Davidson et al., 2012). 
To extend our termination studies to ANET-seq we employed the CMA302 (S2P) Pol II 
antibody, as S2P CTD strongly correlates with 3' end processing (Ahn et al., 2004; Hirose and 
Manley, 1998). Metagene analyses of ANET-seq/S2P using control siRNA treatment (siLuc), 
illustrated significant Pol II pausing at the TES (Figure 6A) as with untreated cells (Figure 
S6). Interestingly, depletion of CPSF73 and CstF-64+CstF-64 tau proteins substantially 
reduced S2P Pol II pausing over the TES (Figure 6A, top and middle). In contrast Xrn2 
knockdown showed no significant difference to the siLuc control (Figure 6A, bottom). We 
also observe that ANET-seq/S2P profiles upon knockdown of CPA factors crossed over the 
siLuc control profile approximately 2.5 kb downstream of the TES (Figure 6A, top and 
middle). ANET-seq on the specific genes GABARAPL1 and SMOC1 revealed that S2P Pol II 
pausing was suppressed by depletion of CPA factors and both ANET-seq and ChrRNA-seq 
show clear termination defects. Again Xrn2 depletion showed no significant effects in these 
assays (Figure 6B). A further S2P Pol II pausing effect was detected 10kbp downstream of the 
SMOC1 TES suggesting that S2P Pol II is paused in the 3' flanking region in a CPA factor 
independent manner. This effect may relate to nucleosome barriers, as previously described 
(Grosso et al., 2012). 
We examined the Read-Through Index (see Experimental Procedure) following 
termination factor knockdown (Figure 6C). RTI demonstrates that depletion of CPA factors, 
but not Xrn2 decreases S2P Pol II occupancy within 2 kb downstream of the TES. This 
indicates that Xrn2 does not have a unique role in Pol II termination at TES. In contrast CPA 
factors promote Pol II pausing to enhance PAS recognition and PAS-dependent termination 
(Figure 6D). 
We also analyzed the ANET-seq and ChrRNA-seq profiles for replication dependent 
histone genes (Schumperli, 1988). These small Pol II transcripts are intronless, not 
polyadenylated and associated with different Pol II CTD modifications; S7P (Egloff et al., 
2007) and T4P (Hsin et al., 2011). We show that ANET-seq profiles appear quite different for 
these genes as compared to other protein coding genes. No TSS associated pausing or 
antisense transcription is evident and highest signals were observed for unphosphorylated 
CTD (Figure S7A). Also depletion of termination factors had different affects. CPSF73 
knockdown gave a clear termination defect based on ChrRNA-seq (Figure S7B) consistent 
with the known association of CPSF with the histone 3’processing machinery (Kolev and  
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Steitz, 2005). Neither CstF64 with CstF64t nor Xrn2 depletion caused termination defects. 
Notably Xrn2 depletion significantly increased ChrRNA-seq levels across histone genes 
implying a major role in RNA stability (Davidson et al., 2012). Finally these termination 
factor knockdowns had no effect on TES pausing, in contrast to other protein coding genes 
(Figure S7C). Overall ANET-seq on histone gene nascent transcription reveals the potential 
for major differences between different gene classes. 
 
4.6 3' end termination machinery regulates metabolism of promoter-associated RNA 
Although RNA cleavage sites have been previously identified near TSS (Almada et al., 
2013), which factors are involved in this process has not been determined. We therefore 
performed metagene analyses across TSS using ANET-seq/S2P following knockdown of CPA 
factors and Xrn2. CPSF73 contains the CPA cleavage activity and so could potentially cleave 
nascent RNA near the TSS by recognition of cryptic PAS. Interestingly we observe an 
equivalent increase in TSS-associated S2P Pol II pausing on both mRNA and PROMPT 
strands after depletion of CPA factors and Xrn2 (Figure 7A). Metagene analysis of CstF-
64+CstF-64 tau double-knockdown shows an average 3.6 fold increase as compared to siLuc 
(Figure 7A middle). Also CPSF73 and Xrn2 knockdowns both show an average 2.3 fold 
increase in Pol II pausing. These effects extend from TSS+30 to TSS+100 on both mRNA and 
PROMPT strands (Figure 7A, top and bottom). Similar effects (average 3.1 (max 9.7), 6.0 
(max 19), 5.7 (max 26.4) fold increase with siCPSF73, siCstF-64+siCstF-64 tau and siXrn2, 
respectively) were observed for the SLC30A6 gene (Figure 7B). The Escaping Index (EI) on 
over 2624 genes show that depletion of all three factors increases promoter-associated S2P 
Pol II pausing (Figure 7C). Additionally, EI also demonstrates that all three factors when 
knocked down have no effect on S2P Pol II distribution across the gene body (Figure 7C).  
Figure 6. Nascent RNA within S2P Pol II complex at TES. 
(A) Metagene analysis of ANET-seq/S2P over TES regions following termination factor depletions (Fig. 5). Data are mean 
+/- SE from 1,647 genes. 
(B) ANET-seq/S2P (top) and ChrRNA-seq (bottom) of GABARAPL1 and SMOC1 gene TES from indicated siRNA treated 
HeLa cells.  
(C) Read-Through Index (RTI) of ANET-seq/S2P following indicated knockdowns. RTI scheme is shown. Gene body (GB) 
signals were divided by signals in 2kb region from TES (TES+2k) for RTI (see Experimental Procedures). X in each 
boxplot marks the mean, and the dashed line is the median of siLuc. n=2,624. (**) P-value < 2 x 10-15 by two-sided Mann-
Whitney test; (ns) indicates no difference between samples (p-value = 0.9894 by two-sided Mann-Whitney test). 
(D) Model correlating Pol II pausing and PAS-dependent transcription termination at TES. RNA cleavage (scissors) by CPA 
complex (red circle) at PAS (orange triangle). Pol II elongation speed over 3' flank region is regulated by PAS recognition. 
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These results indicate that CPA factors and Xrn2 are involved in the metabolism of promoter-
associated non-productive transcripts.  
In order to examine whether CPA factors could directly bind to nascent RNA near TSS, we 
analyzed in vivo cross-linking and immuno-precipitation (CLIP) data which has been 
published for a genome wide alternative polyadenylation (APA) study at TES (Martin et al., 
2012). Surprisingly all CPA factors, including CPSF73, CstF-64, CstF64 tau, CPSF160, 
CPSF30 and CF Im25 proteins, are significantly detected on both strands within 500 nt of the 
TSS. Especially CPSF73 shows a substantial peak 160 nt upstream and 80 nt downstream of 
TSS (Figure 7D and Supplementary Table S1). Together with our ANET-seq/S2P results, we 
conclude the CPA complex cleaves not only pre-mRNA at the PAS to promote 3' end 
termination, but also promotes promoter-associated premature termination (Figure 7E). 
Notably Xrn2 plays a unique role in TSS but not in TES termination. 
  
Figure 7. Promoter-associated RNA metabolism regulated by termination factors. 
(A) Metagene analyses of ANET-seq/S2P following knockdown of 3' end termination factors (Figure 5) at TSS. ANET-
seq/S2P from siLuc, siCPSF73, siCstF64+siCstF64t and siXrn2 treated cells. Data are mean +/- SE from 1,647 genes. 
(B) ANET-seq/S2P maps with indicated knockdowns around TSS of SLC30A6 gene on both mRNA and PROMPT 
strands. 
(C) Escaping Index (EI) and normalized gene body (GB) profiles of ANET-seq/S2P. Representation of EI is shown 
above. GB signals were divided by signals in promoter region (PRO, -50 to +250 bp over TSS) for EI. The EI (left) and 
normalized GB (right) with indicated siRNA treatments are shown below. (***) P-value < 2.2 x 10-16 by two-sided Mann-
Whitney test. 
(D) CLIP analysis of CPA factors (Martin et al., 2012). Relative normalized counts and distance from TSS are shown at 
Y- and X-axis. 
(E) Model showing effects of CPA factors and Xrn2 throughout a gene highlighting TSS and TES differences. 
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5. Discussion 
 
We present a powerful high-throughput sequencing strategy for mapping nascent RNA within 
the elongating Pol II complex across the human genome referred to as ANET-seq. This 
approach reveals precise maps of not only nascent RNA, but also the associated Pol II "CTD 
code". It is widely known that Pol II CTD heptad repeats are dynamically modified during the 
transcription cycle in eukaryotes (Brookes and Pombo, 2009; Egloff et al., 2012a; Heidemann 
et al., 2013). Thus we employed a S2P Pol II specific antibody to monitor transcription 
termination events (Figure 6), since CTD Ser
2
 is highly phosphorylated at the TES where it 
acts to recruit the cleavage and polyadenylation (CPA) complex (Ahn et al., 2004). S2P CTD 
has also been shown to enhance CPA activity in vitro (Hirose and Manley, 1998). ANET-
seq/S2P illustrates more coverage over the TES compared to other Pol II antibodies (Figure 
2E). It also shows clear termination defects upon knockdown of CPA factors (Figure 6A). 
These data were coupled with Chromatin associated RNA sequencing (ChrRNA-seq). 
We also used the S5P CTD specific antibody in ANET-seq analysis. Surprisingly, this 
demonstrates peaks at the 3' ends of actively spliced exons (Figure 3C-F) indicating that the 
upstream exon within the spliceosome is tethered to the Pol II elongation complex in a S5P 
dependent manner. Unspliced exons show much less peak compared to actively spliced exons. 
Furthermore the mutually exclusive exons of PKM show a selective peak of ANET-seq/S5P 
on exon 10, which is predominantly selected in HeLa cells (Figure 3H). Our ANET-seq 
technology will provide a novel way to unravel the complexity of the co-transcriptional 
splicing mechanism since it is possible to isolate a native splicing intermediate (C complex) in 
vivo (Figure 3B). Additionally, this technology may be useful to characterize recursively 
spliced introns as reported in Drosophilla (Burnette et al., 2005; Hatton et al., 1998). Thus 
ANET-seq/S5P peaks across introns may signify recursive 5’SS. 
It has been reported that other CTD amino acids are highly phosphorylated during active 
transcription. For instance, phosphorylation of CTD Ser
7
 (S7P) is important to recruit 
Integrator complex. This regulates 3' end processing of snRNA genes and so facilitates 
transcription termination (Egloff et al., 2007; Egloff et al., 2012b). Additionally, ChIP analysis 
in yeast has shown that S7P Pol II is intron enriched suggesting a link to pre-mRNA splicing 
(Kim et al., 2010). Mutation of CTD Thr
4
 specifically represses histone gene expression 
suggesting that T4P is required for histone mRNA 3' end processing (Hsin et al., 2011). 
Another CTD phosphorylation Tyr
1
 (Y1P) stimulates the binding of elongation factor Spt6 
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and blocks recruitment of termination factors in yeast (Mayer et al., 2012). Use of these 
different phosphorylation-specific Pol II antibodies may provide comprehensive maps of 
nascent RNA with all mammalian CTD codes. 
The mechanistic and kinetic link between Pol II transcription and pre-mRNA splicing is 
well established (David and Manley, 2011; Moore and Proudfoot, 2009; Shukla and 
Oberdoerffer, 2012). In yeast, high resolution nascent RNA mapping and ChIP experiments 
have demonstrated that splicing-dependent Pol II pausing occurs in intron containing genes 
(Alexander et al., 2010; Carrillo Oesterreich et al., 2010; Chathoth et al., 2014). Similarly in 
Drosophila, Pol II pausing at 3' SS was detected by PRO-seq analysis (Kwak et al., 2013). 
However, the connection between co-transcriptional splicing and Pol II pausing in mammals 
has not been described. It has however been reported that phosphorylated Pol II CTD is 
important to recruit splicing factors onto spliced exons and so facilitate splicing efficiency 
(Ahn et al., 2004; Hirose et al., 1999). Furthermore alternative splicing of the multi exonic 
CD44 gene is associated with accumulation of S5P over variant exons (Batsche et al., 2006). 
Our nascent RNA profiles from ANET-seq (Figure 3) suggest new interpretations. Thus 
ANET-seq signals are enriched at 5’SS rather than at intron 3’ ends as seen in yeast 
(Alexander et al., 2010). This may relate to differences between the intron definition model 
proposed for yeast and exon definition models for human splicing. It is thought that introns 
are recognized for splicing in lower species, since their lengths are generally much shorter 
than in mammals. On the other hand, an exon may need to be preferentially recognized by Pol 
II in mammals since here exons represent a very small part of the mainly intronic pre-mRNA. 
Our results are also consistent with exon-tethering models where upstream exons are retained 
on the elongating Pol II complex to facilitate splicing with downstream exons (Dye et al., 
2006). Importantly, CTD S5P is involved in this exon-tethering model. It remains a possibility 
that other CTD modifications are also required for intron definition.  
A substantial fraction of pre-miRNA are found in the introns of protein coding genes 
(Rodriguez et al., 2004). We show ANET-seq peaks that precisely delineate these intronic pre-
miRNA sequences and are enriched for S2P and S5P (Figure 4A-D). Previous reports indicate 
co-transcriptional pre-miRNA processing can occur on chromatin by recruiting the 
microprocessor complex (Drosha and DGCR8 proteins) to these pri-miRNA sequences 
(Morlando et al., 2008). We show here that the kinetics of pre-miRNA biogenesis varies 
involving both co-transcriptional and post-transcriptional pre-miRNA processing events.  
Pol II accumulation at TES also has been revealed by ChIP experiments and GRO-seq 
analysis (Core et al., 2008; Davidson et al., 2014; Proudfoot, 2011). It was thought that Pol II 
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pausing at TES regulates transcription termination, based on NRO analysis (Gromak et al., 
2006). In addition, PAS comprising both an AAUAAA core sequence and downstream GU 
rich sequence element (DSE) are required for cleavage and polyadenylation (CPA) at the TES. 
Biochemical experiments isolated and characterized the cleavage and polyadenylation 
specificity factor (CPSF) complex and cleavage stimulating factor (CstF) complex from HeLa 
nuclear extracts. These protein complexes recognize the AAUAAA and GU-rich DSE, 
respectively. Importantly, CPA is functionally linked to Pol II transcription termination in vivo 
(Proudfoot, 2011). Here, we depleted components of the CPA complex (CPSF73 and CstF-
64+CstF-64 tau) in HeLa cells using siRNA technology to examine the effect on Pol II 
pausing at TES. Consistent with previous reports, ChrRNA-seq reveals that siRNA-mediated 
CPSF73 and CstF-64 depletion causes transcriptional termination defects on protein-coding 
genes (Figure 5). Interestingly, our ANET-seq data shows that depletion of CPA factors causes 
significantly less pausing immediately downstream of TES (<2 kb from TES) and then more 
Pol II occupancy at further downstream region (> 2kb from TES) compared to siLuc 
transfected cells (Figure 6A). This result indicates that Pol II elongation speed is regulated by 
the CPA complex which may be important to mediate transcription termination at protein 
coding gene TES (Figure 6C). Moreover, depletion of CPA factors in some cases caused 
additional pausing further downstream of PAS-dependent Pol II pause site (Figure 6B, for 
examples GABARAPL1 and SMOC1 genes). This suggests other Pol II pausing mechanisms 
exist such as nucleosome barriers (Grosso et al., 2012; Mavrich et al., 2008), road blocks 
caused by DNA-binding protein (Shukla et al., 2011) or co-transcriptional RNA cleavage 
(CoTC) (Dye and Proudfoot, 2001; Nojima et al., 2013) in the termination region, possibly 
acting as fail-safe termination mechanisms.  
We also demonstrate that no significant termination defect occurs following the TES upon 
knockdown of Xrn2 (Figure 6A, bottom). This observation is inconsistent with our previous 
reports which employed plasmid-based transfection studies (West et al., 2004). Additionally, it 
has been shown recently that Xrn2 has a required partner protein TTF2 for transcription 
termination (Brannan et al., 2012). It seems likely that Xrn2 associated termination is 
redundant with other termination factors. 
Unexpectedly, ANET-seq analysis showed a drastic increase in Pol II pausing at the TSS 
(<100 base) for both mRNA and PROMPT transcription upon knockdown of CPA factors. 
Additionally, depletion of 5'-3' exonuclease Xrn2 also showed a similar increase in Pol II 
pausing at the TSS. This result suggests that Xrn2 is involves in premature termination at the 
TSS even though it may not play such a critical role at the TES (Brannan et al., 2012). 
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Although CPA factors and Xrn2 affects Pol II occupancy at TSS, all three protein knockdowns 
show no difference in Pol II distribution across the gene body.  
Recent studies have pointed towards differences between promoter proximal termination 
for mRNA sense or antisense RNA (Almada et al., 2013; Grzechnik et al., 2014; Ntini et al., 
2013). Antisense TSS transcripts (PROMPTs) are thought to utilize cryptic PAS close to the 
TSS while sense TSS transcripts may have reduced occurrence of cryptic PAS. Those that are 
present are thought to be blocked by nearby 5’SS U1snRNP recruitment (Kaida et al., 2010). 
These apparent differences in cryptic PAS usage between PROMPTs and sense TSS 
associated transcripts have been proposed to favor productive sense over non-productive 
antisense transcription. In contrast our ANET-seq data argue that CPA factors and Xrn2 play 
equivalent roles in restricting sense and antisense TSS transcription. Thus their depletion by 
siRNA treatment causes an equivalent increase in Pol II pausing in both transcriptional 
directions. We also show that CPA factors are directly and equally associated with these two 
transcript classes by CLIP analysis (Martin et al., 2012). Our data suggest that transcriptional 
directionality at TSS is unlikely to be regulated by CPA mediated termination. Rather both 
sense and antisense TSS associated transcripts are restricted by normally TES associated 
termination factors. Indeed we observe a redistribution of S2P Pol II from the TES to the TSS 
following CPA factor and Xrn2 knockdown. This argues for close interconnections between 
both ends of the Pol II transcription unit, as previously demonstrated by 3C analysis (Ansari 
and Hampsey, 2005; O'Sullivan et al., 2004; Tan-Wong et al., 2012).  
Overall, the ANET-seq method shows Pol II pausing and RNA cleavage resulting in 3’OH 
at RNA 3’ ends at single-nucleotide resolution. Critically the ANET-seq method can be 
applied to genome-wide analyses to check the occupancy of modified polymerase (even Pol I 
and Pol III) by selecting a range of different antibodies to pull down the associated nascent 
RNA. Furthermore ANET-seq can be applied to search for novel non-coding RNA that are 
rapidly degraded. We anticipate that ANET-seq will expand our knowledge of how different 
nascent RNA are associated with specific "CTD codes". This will illuminate the complexities 
of co-transcriptional RNA processing and regulated gene expression. 
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6. Experimental Procedures 
Antibodies 
Pol II antibodies CMA301, CMA302 and CMA303 were generated by Dr. H. Kimura 
(Stasevich et al., 2014). 8WG16 and Aly antibodies were purchased from Abcam. CPSF73, 
CstF-64 and CstF-64 tau antibodies were purchased from Bethyl laboratories. -Tubulin 
antibody was purchased from Sigma. Xrn2 antibody was provided by Dr. N. Gromak. 
 
Cell culture, NRO assay and RT-PCR 
Cell culture and NRO assay were as previously described (Nojima et al., 2013). siRNA 
transfection, RT-PCR and primers are described in Extended Experimental Procedures. 
 
ANET-seq, ChrRNA-seq and bioinfomatical analysis 
ANET-seq and ChrRNA-seq were conducted according to Figure 1A and Supplemental 
Figure S2. For further details, data processing and bioinfomatical analysis see Supplemental 
Experimental Procedures. 
 
 
ACCESSION NUMBERS 
The accession number for sequence data will be submitted shortly in NCBI's gene Expression 
Omnibus. 
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can be found with the Article online. 
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8. Supplementary Material 
 
8.1 Extended experimental procedures 
 
siRNA transfection 
SMARTpool siRNA against human CPSF73 (CPSF3) and CstF64 (CSTF2) were purchased 
from Thermo scientific. ON-TARGET plus siRNA against Xrn2 was made by Thermo 
Scientific as following sequences. Sense: AAGAGUACAGAUGAUCAUGUU, Antisense: 5'-
P CAUGAUCAUCUGUACUCUUUU.  Silencer select siRNA against CstF64 tau (CSTF2T) 
was designed by Life technologies as following sequence, Sense: 
CCAUUAUUGACUCACCCUAtt, Antisense: UAGGGUGAGUCAAUAAUGGgc. These 
siRNA (final conc. 30nM) were transfected into HeLa cell using Lipofectamine RNAiMAX 
reagent (Life technologies) according to the manual and incubated for 72 hours. 
 
RT-PCR analysis 
RNA was isolated from HeLa cells and cells were transfected with Trizol. For reverse 
transcription, 500 ng of total RNA was incubated with oligo (dT)20 and Superscript II reverse 
transcriptase (Life Technologies). PCR was performed using GO taq polymerase (Promega) 
and following primer set.  
PKMex8_Fw: 5'- GATGGAGCCGACTGCATCATG -3',  
PKMex11_Rv: 5'- ATTCCGGGTCACAGCAATGAT -3' 
PCR products were digested by either NcoI (NEB) or PstI (NEB) for six hours. The PCR 
products were analyzed by 2% agarose gel electrophoresis, followed by ethidium bromide 
staining. 
 
Chromatin-bound RNA (ChrRNA)-seq method and RNA library preparation 
Chromatin RNA fraction was prepared from ~80% confluent HeLa cells in 100mm Dishes. 
Approximately 7x10
6 
cells were washed with ice-cold PBS twice. The cells were lysed with 
ice-cold 4 ml of HLB/NP40 buffer (10 mM Tris-Hcl pH 7.5, 10 mM NaCl, 0.5% NP40 and 
2.5 mM MgCl2) and incubated on ice for 5 min. After the incubation, 1 ml of ice-cold 
HLB/NP40/Sucrose buffer (10 mM Tris-HCl pH 7.5, 10 mM NaCl, 0.5% NP40, 2.5 mM 
MgCl2 and 10 % Sucrose) was under-laid and then the nuclei were collected under 1,400 rpm 
centrifuge at 4
0
C for 5 min. Isolated nuclei were resuspended in 1.25 l of NUN1 solution (20 
mM Tri-HCl pH 8.0, 75mM NaCl, 0.5 mM EDTA, 50% Glycerol and proteinase inhibitor 
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1xComplete (Roche)) and added 1.2 ml NUN2 buffer (20 mM HEPES-KOH pH 7.6, 7.5 mM 
MgCl2, 0.2 mM EDTA, 300 mM NaCl, 1 M Urea, 1% NP40, proteinase inhibitor 1xComplete 
and phosphatase inhibitor 1xPhosStop (Roche)). 15 min incubation was carried out on ice 
with mixing by max speed vortex for 5 sec every ~4 min and then chromatin pellets were 
precipitated under 13,000 rpm centrifuge at 4
o
C for 10min. Chromatin pellet was resuspended 
in 200 l HSB (10mM Tris-HCl pH 7.5, 500 mM NaCl and 10 mM MgCl2) with 0.25 U/l 
TURBO DNase (Life technologies) at 37
o
C for 10 min and then treated with Proteinase K for 
10 min. RNA was extracted by Trizol reagent (Life technologies). This extraction steps were 
repeated three times.  
 
In prior to RNA library preparations, rRNAs were depleted using Ribo-Zero rRNA removal 
kits (Epicentre) from 5 g of Chromatin RNA. RNA was also fragmented 150-200 nt by heat 
treatment (94 
o
C) for 15 min in 1xNEB first strand synthesis buffer. 100 ng or chromatin RNA 
was used for RNA library preparations. These were carried out according to NEBNext Ultra 
Directional RNA Library Prep kit for Illumina (NEB). Deep sequencing using Hiseq2000 and 
Hiseq2500 were performed by the Wellcome Trust Centre for Human Genetics (WTCHG) 
Oxford UK. 
 
ANET-seq method and RNA library preparation 
Approximately 1.6x10
8 
cells were used to generate nuclear and chromatin fractions. Isolated 
chromatin was washed in 1 ml of 1x Micrococcal Nuclease (MNase) buffer (NEB) and then 
incubated with MNase (40 u/L) on Thermomixer (eppendorf, 1,400 rpm) at 37oC for 90 sec. 
In order to inactivate MNase, EGTA (25 mM) was added immediately after the reaction and 
soluble digested chromatin was collected by 13,000 rpm centrifuge for 5 min. The supernatant 
was diluted with 9 ml of NET-2 buffer and add Pol II antibody-conjugated beads. 40 g of Pol 
II antibody was used for each ANET-seq experiment. Immunoprecipitation was performed at 
4
o
C for one hour. The beads were washed with 1 ml of NET-2 buffer six times and with 500 
l of 1xPNKT (1xPNK buffer and 0.05 % Triton X-100) buffer once in the cold room. The 
washed beads were incubated in 100 l of PNK reaction mix (1xPNKT, 1 mM ATP and 0.05 
U/ml T4 PNK 3'phosphatase minus (NEB) ) on Thermomixer (1,400 rpm) at 37
o
C for 6 min. 
After the reaction the beads were washed with 1 ml of NET-2 buffer once and RNA was 
extracted with Trizol reagent.  
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RNA was resolved on 8 % denaturing acrylamide 7 M urea gels for size purification. 35-100 
nt fragments were eluted from the gel using RNA elution buffer (1 M NaOAc and 1 mM 
EDTA) and RNA was precipitated in 75 % Ethanol. RNA libraries were prepared according to 
the manual of Truseq small RNA library prep kit (Illumina). Deep sequencing was conducted 
by WTCHG in Oxford. 
 
Analyses of in vivo Cross-linking and Immuno-precipitation (CLIP) assay for TSS 
CLIP-sequencing datasets (Martin et al., 2012) were downloaded for the following 
transcription factors, CPSF-73, CstF-64, CstF-64tau, CPSF-160, CPSF-30 and CF-Im25. 
Normalized read counts were calculated for sense and antisense strands relative to the 
direction of gene transcription for a region of 3 kb upstream and downstream of annotated 
Refseq TSS and plotted for 10 bp bin (Supplementary Table S1). 
 
Data pre-processing  
ANET-seq data adaptors were trimmed using Cutadapt (v1.1) (Martin, 2011), discarding reads 
with less than 10 bases. Then a Perl script was used to remove the reads left unpaired. The 
remaining reads were then aligned to the reference human genome (hg19) using TopHat 
(v2.0.9) (Kim et al., 2013) with a minimum anchor length of 5 bases, and only allowing for 
one alignment to the reference. It was necessary to determine the last nucleotide incorporated 
by the polymerase and its directionality. This nucleotide was defined as the 5’ end of read two 
of the pair, with the directionality indicated by read one. Knowing this, the properly aligned 
pairs of reads were trimmed to solely keep the 5’ nucleotide of read two. This was done using 
SAMtools (Li et al., 2009) and a python script. SAMtools was also used to separate the reads 
by strand for further analysis. 
ChrRNA-seq data was aligned using the same version of TopHat, but allowing for the read 
pairs to be separated by 3kb. For the metagene representation, SAMtools was used to separate 
the reads by strands. 
ChIP-seq data for unphosphorylated Pol II, H3K4m3 and H3K36m3 (GEO accession numbers 
GSM935395, GSM945201 and GSM733711, respectively) were generated as part of the 
ENCODE Project (Consortium et al., 2012). 
 
Determination of expressed genes 
To determine the genes expressed in HeLa S3 cells, strand-specific RNA-seq data from a 
previously published study (Lacoste et al., 2014) was used (GEO accession number 
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GSM1155630). The data was aligned with TopHat and then Cufflinks (v2.1.1) (Trapnell et al., 
2010) was used to acquire a FPKM value for each gene. These values were then converted to 
log2 and their distribution was plotted. The cut off value chosen to determine the expressed 
genes was the local minimum of the log2 (FPKM) distribution between the primary peak of 
high expression genes and the long left shoulder of low-expression transcripts as previously 
reported (Hart et al., 2013). This defined 11560 expressed genes, of which 10473 were protein 
coding. From these genes a further selection of ones where the gene body and the adjacent 
regions (TSS-1000bp and TES+3kbp) do not intersect other genes was made. This resulted in 
1647 genes used to generate the metagene profiles. 
  
Metagene profiles 
The metagene profiles represent average profiles across expressed genes for Pol II or RNA 
abundance. To generate these, genes were aligned by their annotated TSS and TES. The 5’ 
end, showing a span of 1kb up and downstream of the TSS, and the 3’ end, showing the 
interval from TES-500bp to TES+3kb, were unscaled and averaged in a 5bp window. The 
remaining gene body was scaled to 100 equally sized bins, so that all the genes appear the 
same length. 
Metagene profiles were generated using this same method, but the window around the TSS 
extended from TSS-250 bp to TSS+250 bp, and around the TES from TES-250 bp to TES+1 
kb. 
The individual profiles were plotted in single base windows and using a scale of reads per 10
8
 
sequences. 
  
Determination of included and excluded exons 
To determine if alternative exons were included or excluded in the transcripts produced, 
previously described RNA-seq data used for determining expressed genes was analysed with 
MISO (Katz et al., 2010). These results were compared to RefSeq exon reference data. Exons 
were then divided according to the Ψ-value calculated by MISO, which indicates the fraction 
of inclusion of an exon predicted for a dataset. Only exons with more than 0.9 or less than 0.1 
were considered included or excluded, respectively. 
 
Escaping and Read-Through Index 
Escaping Index (EI) is defined as the proportion of Pol II from the TSS that proceeds to the 
elongation phase of transcription. It was calculated as follows: 
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𝐸𝐼 = log2 (
𝐺𝐵
𝑇𝑆𝑆
+ 𝑐),  𝑐 =
min (
𝐺𝐵
𝑇𝑆𝑆
>0)
2
 
 
where GB is the Reads per Kilobase per Milion reads (RPKM) of sense reads in the interval 
[TSS+500, TES], TSS is the RPKM of sense reads in [TSS-50, TSS+250]. The constant c was 
used to log the zeros in the data. The first 500 bases of each gene are excluded from the 
definition of the gene body to prevent TSS polymerase accumulation from interfering with the 
counts for the gene body. 
The Read-Through Index was calculated using the same approach, but instead of considering 
the TSS interval, the RPKM of sense reads for [TES, TES+2000] was used. 
Normalized Gene Body counts use the same formula but without dividing the RPKM from the 
gene body region by any of the others. 
Significance of the differences between control and knock-down for each index was 
calculated using a two-sided Mann-Whitney test. The p-values were then adjusted using the 
Holm method. 
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PCR Primers sequences for ChIP assay 
GAPDH_TSS_F 5'-cggctactagcggttttacg-3' 
GAPDH_TSS_R 5'-gctgcgggctcaatttatag-3' 
GAPDH_int1_F 5'-CCCCTTCATACCCTCACGTA-3' 
GAPDH_int1_R 5'-GACAAGCTTCCCGTTCTCAG-3' 
GAPDH_I6E7_F 5'-acccagaagactgtggatgg-3' 
GAPDH_I6E7_R 5'-ttcagctcagggatgacctt-3' 
GAPDH_PAS_F 5'-CTGAATCTCCCCTCCTCACA-3' 
GAPDH_PAS_R 5'-TGCCCCAGACCCTAGAATAA-3' 
GAPDH_PAS+1.1k_F 5'-TCCAGCCTAGGCAACAGAGT-3' 
GAPDH_PAS+1.1k_R 5'-TGTGCACTTTGGTGTCACTG-3' 
IST1_-2k_F 5'-TGTTAGCCAGGGTGGTCTTC-3' 
IST1_-2k_R 5'-GGTCAGGAGTTGGAGAGCAG-3' 
IST1_TSS_F 5'-aaccctgaagtcggtgtctg-3' 
IST1_TSS_R 5'-ctccgaagtcgtttgaatcc-3' 
IST1_B_F 5'-caccatgcccagctaatttt-3' 
IST1_B_R 5'-accctcaggtggttctgatg-3' 
IST1_LE_F 5'-tgaaggcctcgcttagttgt-3' 
IST1_LE_R 5'-gcaccttgtcctttctctgc-3' 
IST1_+4k_F 5'-TCCGCTGTCACTGCATAAAC-3' 
IST1_+4k_R 5'-TTCCCATGGAGAGGAACATC-3' 
MYC_TSS_F 5'-gggatcgcgctgagtataaa-3' 
MYC_TSS_R 5'-cctattcgctccggatctc-3' 
MYC_I2_F 5'-tggcagggagtgtatgaatg-3' 
MYC_I2_R 5'-cacccactcttgaggcagtt-3' 
MYC_+0.8K_F 5'-ACATCAACCCCATGAAGGAG-3' 
MYC_+0.8K_R 5'-GTGGCTTGGACAGGTTAGGA-3' 
MYC_+2.5k_F 5'-GATGGAGACCATCCTGGCTA-3' 
MYC_+2.5k_R 5'-ATGCAGTGGCACAATCTCAG-3' 
 
 
 
Supplementary Table - p-values of every two-sided Mann-Whitney test for every index, 
before and after adjusting using the Holm method 
 
sample (vs. 
siLuc) 
EI RTI GB 
before 
adjusting 
after 
adjusting 
before 
adjusting 
after 
adjusting 
before 
adjusting after adjusting 
siCPSF73 3.53E-63 3.53E-63 9.72E-16 1.94E-15 0.0087335989 0.0087335989 
siCstF64si64t 1.36E-138 4.08E-138 3.34E-20 1.00E-19 0.0008596245 0.0017192490 
siXrn2 6.23E-72 1.25E-71 0.9894088 0.9894088 0.0000645689 0.0001937067 
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8.2 Supplementary Figures 
 
 
 
 
Figure S1. Pol II phosphorylation in different fractions 
HeLa cell extracts were prepared from whole cell (WCE), whole nuclei, chromatin and nucleoplasm fractions. Two major 
phosphorylated forms of Pol II, hypophosphorylated (Pol IIa) and hyperphosphorylated Pol II (Pol IIo) were detected by 
western blot using 8WG16 Pol II antibody. H3 was detected as a chromatin marker. 
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Figure S2. Detailed ChrRNA-seq and ANET-seq methods, Related to Figure 1 
(Right) ChrRNA-seq method. Chromatin-bound RNA (red line) is purified from isolated chromatin fraction by 
micrococcal nuclease (MNase1) and proteinase K treatments. Pol II and RNA synthesizing site are shown as tailed blue 
box and orange asterisk, respectively. RNA is fragmented to 150-200 nt by heat and adapters ligated on both ends for 
paired-end 51bases directional deep sequencing (blue and green arrows).  
(Below) ANET-seq method. Chromatin DNA and chromatin-bound RNA are digested with MNase I (light blue scissors). 
To separate insoluble pellet (P) and soluble chromatin supernatant (S), digested chromatin is centrifuged. Soluble Pol II-
nascent RNA complex is immuno-precipitated (IPed) with Pol II antibody. 5' hydroxyl (OH) is then phosphorylated with 
PNK on beads and phenol extraction performed to remove DNA and proteins. IPed RNA is purified from denaturing gel 
(size range 35-100 nt). RNA adapters are added to both ends strand-specifically and deep sequencing is conducted from 
reverse sequence primer (green arrow) to read 3' end of insert (orange asterisk). 
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Figure S3. Gene specific ChIP analysis using indicated Pol II antibodies, Related to Figure 2 
Pol II ChIP was conducted with indicated Pol II antibodies on GAPDH, IST1 and MYC genes. Positions of primer sets 
and PAS are shown by red bars and green triangles, respectively. TSS denoted by black arrow. 
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Figure S4. Overlapping gene units 
(A) Example of overlapping genes. ChrRNA-seq signals from P2RY11 (dark blue) and EIF3G (dark red) genes overlap at 
their TES.  
(B) Selection criteria of non-overlapping (N-Ov) genes. Genes of interest, A (green) are isolated from neighboring genes. 
Gene B is 1 kb upstream of gene A TSS. Gene C is 3 kb downstream of gene C TES. Blue and red arrows show 
transcription direction. 
(C) 11231 genes are selected as expressed genes in HeLa cell. 1647 genes are not overlapping based on criteria set in (B). 
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Figure S5. Further examples of pre-miRNA ANET-seq and ChrRNA-seq profiles, Related to Figure 3 
ANET-seq analysis with unph, S2P, S5P and unph+ph antibodies compared with ChrRNA-seq and small RNA-seq profiles for hsa-mir-21 (A), 
MIR17HG (B), hsa-mir-193a (C) and has-mir-103a-1 (D). Details as for Figure 4 legend. Note MIR17HG harbors polycistronic pre-miRNAs. 
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Figure S6. Comparison of siLuc control treated ANET-seq with untreated profiles, Related to Figure 6 
siLuc treated HeLa cell ANET-seq/S2P metagene profile over TES compared with untreated cell replicates. See Figure 6 
legend for further details. 
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Figure S7. Histone gene ANET-seq and ChrRNA-seq profiles. 
(A) Histone metagene analysis using ANET-seq with different Pol II CTD antibodies compared to ChrRNA-seq. 
(B) ChrRNA-seq following termination factor knockdown by siRNA. See Figure 5 legend.  
(C) ANET-seq/S2P following termination factor knockdown by siRNA. See Figure 5 legend. 
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Conclusions and Perspectives 
 
Evolution of research methodologies in life sciences has come a long way in the last fifty 
years. In the past, technical hindrances limited the understanding of biological systems, which 
invariably led to having a narrow scope when taking conclusions from data. This did not hold 
back the growth of knowledge, yet many questions were raised because of the high variability 
and noise in collected data, and few were answered at that time. Only with technology 
development and constant increase in throughput became clear that living systems are far 
more complex, and the web of interactions in a cell is far more intricate than first imagined, 
with some degree of functional redundancy that could justify the questions before raised. It is 
therefore crucial that high-throughput techniques are utilized in regulation studies, so as to 
accurately draw the big picture of biological functioning. 
ANET-seq is an advantageous improvement in this type of approaches. While NET-seq 
(Churchman and Weissman, 2011) was useful for describing polymerase occupancy in detail, 
its advanced counterpart here described allows the distinction of CTD modifications in data 
interpretation. The Pol II C-terminal domain has been increasingly described as a key 
regulator in transcription and its associated events, and future experiments using this high-
throughput, high-precision system focusing on its various modifications will certainly add 
valuable insights to all fields surrounding transcription. Additionally, extracting this 
information from different circumstances is also of great importance. Like in this study, 
where the use of siRNA opened new perspectives about CPA and termination factors 
function, so other conditions - such as different cell stages, types and organisms – can be 
compared to reveal novel aspects of transcription in concrete scenarios. 
Besides revalidating some of the previous findings about CTD isoform distribution in 
genes, ANET-seq data showed its relationship with splicing and miRNA processing. Constant 
activity of processing machinery is increasingly obvious, but it still surprises the evident 
duality of co and post-transcriptional processes, and what exactly defines these processing 
timing differences. Further investigation is required in order to explain in real time the 
decision-making processes of the cell in regards to transcription. And while it seems clear that 
the signal captured at the end of exons belongs to co-transcriptionally spliced exons, it is not 
yet fully understood how these intermediates are captured and if they can accurately measure 
the degree of splicing that is occurring. 
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Some outstanding knowledge came out from siRNA experiments as well. ANET-seq 
preformed in CPA factors-depleted cells showed a clear decrease in effective transcription 
termination, but not when the removed factor was the termination-related protein Xrn2. 
However, perhaps even more surprising were the differences observed in TSS Pol II 
accumulation when any of the tested factors was removed. These differences pointed to novel 
roles of these factors in early termination, and hinted perhaps on one more motive for gene 
looping that is the sharing of transcription termination factors for early and late transcription. 
This work also showed the great need of a constant cooperation between molecular and 
computational biologists. Increasing complexity in data generation creates a higher demand in 
robust and adaptable bioinformatical tools, so as to extract the significant elements from a 
dataset. It becomes clear, however, that an increase in the number of tools also makes it 
difficult to establish a standard analysis pipeline, thus increasing debate on whether the right 
methodology is being used or not. But this is a positive situation, as it is important to adequate 
the analysis to the data. This is why a good understanding of the workings of the referred 
tools, together with a robust pipeline, is so necessary in these methods, since it allows a clear 
justification of why a specific analysis was preformed. In this particular situation, the aspect 
which is most demanding of the data might be the single-nucleotide resolution of ANET-seq 
reads. Other methodologies have been created in order to make peak calling of ChIP-seq or 
related data, these tools are not suited for working with this kind of data. Hence, it can also be 
argued that this new generation of high-precision sequencing techniques creates a new niche 
for the development of new tools able to accommodate their properties. 
Future research on transcription should make use of emerging high precision tools. Single-
cell technologies are soon to be established, revealing the intercellular variability that is 
currently considered all together, and may consequently help filter some patterns that only 
exist as a result of a mixture of different cells’ information. Integration of ever more clear-cut 
microscopy technologies might also be helpful in tracking individual molecules, which would 
help describe certain events in real time. Finally, a great challenge that is transversal to many 
biology fields is the ability to efficiently mine the continuously growing high-throughput data 
flow. New methods of extracting and presenting information are of great demand wherever 
these technologies apply. As for biological targets, transcription will also have to focus in 
subsets of genes and their transcription, highlighting the expanding topic of non-coding RNAs 
and how they are synthesized and their role in gene expression regulation. It is also of great 
importance to better understand the co-transcriptionally associated phenomena, namely 
splicing and small RNA processing, and how these may change by altering the cellular 
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environment. ANET-seq will certainly be a central point in future studies related to these 
fields, consequently making the capacity for analyzing this type of data a very valuable skill, 
just like it is for RNA-seq or ChIP-seq. 
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